TAO1
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | T949 | Sugiyama | POTEF A26C1B | TVAsSSSLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| A6NMY6 | S164 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | NRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDGS |
| A6NMY6 | S26 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | EILCKLsLEGDHstPPsAyGsVKAytNFDAERDALNIEtAI |
| A8MVM7 | T470 | Sugiyama | None | PESTDSGNTHQTHMEESKRFtLRSHSARQNSFKKQSKEIEN |
| O00165 | S153 | Sugiyama | HAX1 HS1BP1 | PDSHQPRIFGGVLESDARSEsPQPAPDWGsQRPFHRFDDVW |
| O00231 | S298 | Sugiyama | PSMD11 | RYAGRQTEALKCVAQASKNRsLADFEKALTDYRAELRDDPI |
| O00469 | S83 | Sugiyama | PLOD2 | NYTVKVLGQGEEWRGGDGINsIGGGQKVRLMKEVMEHYADQ |
| O14818 | T152 | Sugiyama | PSMA7 HSPC | LIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKSVREFL |
| O15127 | T109 | Sugiyama | SCAMP2 | QEELDRKAAELERKERELQNtVANLHVRQNNWPPLPSWCPV |
| O15143 | S323 | Sugiyama | ARPC1B ARC41 | QNLDKKAssEGGtAAGAGLDsLHKNsVsQIsVLsGGKAKCS |
| O15212 | T107 | Sugiyama | PFDN6 HKE2 PFD6 | IKRYESQLRDLERQsEQQREtLAQLQQEFQRAQAAKAGAPG |
| O15226 | T623 | Sugiyama | NKRF ITBA4 NRF | KRDIEQIIRNYARsEsHtDLtFsRELTNDERKQIHQIAQKY |
| O43390 | T137 | Sugiyama | HNRNPR HNRPR | ESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYS |
| O43615 | T106 | Sugiyama | TIMM44 MIMT44 TIM44 | DEARRLEEsDVLQEARRKyKtIESETVRTSEVLRKKLGELT |
| O43707 | T443 | Sugiyama | ACTN4 | sIHEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDL |
| O43707 | T445 | Sugiyama | ACTN4 | HEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDLAA |
| O43707 | T728 | Sugiyama | ACTN4 | EQQHQLIQEALIFDNKHtNytMEHIRVGWEQLLTTIARTIN |
| O60231 | T50 | Sugiyama | DHX16 DBP2 DDX16 KIAA0577 PRP2 | LIGTAQRCTSAEEFVQRLRDtDTLDLsGPARDFALRLWNKV |
| O60488 | T508 | Sugiyama | ACSL4 ACS4 FACL4 LACS4 | VGAPLICCEIKLKDWQEGGytINDKPNPRGEIVIGGQNISM |
| O60506 | T134 | Sugiyama | SYNCRIP HNRPQ NSAP1 | DSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYS |
| O60664 | S254 | Sugiyama | PLIN3 M6PRBP1 TIP47 | SyFVRLGsLSERLRQHAyEHsLGKLRATKQRAQEALLQLSQ |
| O60664 | T328 | Sugiyama | PLIN3 M6PRBP1 TIP47 | QLQGPEKEPPKPEQVESRALtMFRDIAQQLQATCTSLGSSI |
| O60716 | T869 | Sugiyama | CTNND1 KIAA0384 | FQVNLNNAsRsQssHsyDDstLPLIDRNQKsDKKPDREEIQ |
| O95071 | T119 | Sugiyama | UBR5 EDD EDD1 HYD KIAA0896 | GRTSRPGRTSDsPWFLsGSEtLGRLAGNTLGSRWSsGVGGs |
| O95817 | T242 | Sugiyama | BAG3 BIS | QPsFHQAQKTHyPAQQGEyQtHQPVyHKIQGDDWEPRPLRA |
| O95835 | T1079 | PSP | LATS1 WARTS | DtLNGWYKNGKHPEHAFYEFtFRRFFDDNGYPYNYPKPIEY |
| P00338 | T275 | Sugiyama | LDHA PIG19 | SVADLAESIMKNLRRVHPVstMIKGLYGIKDDVFLSVPCIL |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P00558 | T376 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | MDEVVKAtsRGCItIIGGGDtAtCCAKWNtEDKVsHVstGG |
| P00558 | T378 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EVVKAtsRGCItIIGGGDtAtCCAKWNtEDKVsHVstGGGA |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04406 | T246 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKVVKQAS |
| P04843 | S276 | Sugiyama | RPN1 | VLKGPFSRyDyQRQPDSGISsIRSFKTILPAAAQDVYYRDE |
| P05187 | T181 | Sugiyama | ALPP PLAP | AGKSVGVVTTTRVQHAsPAGtyAHtVNRNWysDADVPASAR |
| P05187 | T185 | Sugiyama | ALPP PLAP | VGVVTTTRVQHAsPAGtyAHtVNRNWysDADVPASARQEGC |
| P05455 | S325 | Sugiyama | SSB | VLEGEVEKEALKKIIEDQQEsLNKWKSKGRRFKGKGKGNKA |
| P05787 | S410 | Sugiyama | KRT8 CYK8 | TYRKLLEGEESRLEsGMQNMsIHtKTTSGYAGGLSSAYGGL |
| P06733 | S291 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IsPDQLADLyKsFIKDyPVVsIEDPFDQDDWGAWQKFtAsA |
| P06733 | S353 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NEKsCNCLLLKVNQIGsVTEsLQACKLAQANGWGVMVsHRs |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | Y287 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | PsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDDWGAWQKF |
| P06748 | S137 | Sugiyama | NPM1 NPM | VAVEEDAEsEDEEEEDVKLLsIsGKRsAPGGGsKVPQKKVK |
| P06748 | S260 | Sugiyama | NPM1 NPM | GPssVEDIKAKMQAsIEKGGsLPKVEAKFINyVKNCFRMtD |
| P07195 | T276 | Sugiyama | LDHB | SVADLIESMLKNLSRIHPVStMVKGMYGIENEVFLSLPCIL |
| P07195 | T302 | Sugiyama | LDHB | YGIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsAD |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07237 | T117 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | RGyPtIKFFRNGDTASPKEytAGREADDIVNWLKKRTGPAA |
| P07355 | S164 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | NRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDGs |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07355 | S26 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | EILCKLsLEGDHstPPsAyGsVKAytNFDAERDALNIEtAI |
| P07437 | S75 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| P07737 | S30 | Sugiyama | PFN1 | NLMADGTCQDAAIVGYKDsPsVWAAVPGKtFVNITPAEVGV |
| P07814 | T1460 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | GKIVQIPFCGEIDCEDWIKKtTARDQDLEPGAPsMGAKSLC |
| P07858 | T218 | Sugiyama | CTSB CPSB | CTGEGDTPKCSKICEPGysPtyKQDKHYGYNSYSVSNSEKD |
| P07900 | S169 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | TVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTKVILH |
| P07900 | T109 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LtIVDtGIGMTKADLINNLGtIAKSGtKAFMEALQAGADIS |
| P07900 | T171 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTKVILHLK |
| P07900 | T645 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MGyMAAKKHLEINPDHsIIEtLRQKAEADKNDKSVKDLVIL |
| P08238 | S164 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | VVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTKVILH |
| P08238 | T104 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LtLVDtGIGMtKADLINNLGtIAKSGtKAFMEALQAGADIS |
| P08238 | T166 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTKVILHLK |
| P08238 | T637 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MGyMMAKKHLEINPDHPIVEtLRQKAEADKNDKAVKDLVVL |
| P08238 | T85 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtI |
| P08238 | T89 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtIAKSG |
| P09211 | T62 | Sugiyama | GSTP1 FAEES3 GST3 | GsLKASCLyGQLPKFQDGDLtLyQsNtILRHLGRTLGLYGK |
| P09211 | T68 | Sugiyama | GSTP1 FAEES3 GST3 | CLyGQLPKFQDGDLtLyQsNtILRHLGRTLGLYGKDQQEAA |
| P09211 | Y64 | Sugiyama | GSTP1 FAEES3 GST3 | LKASCLyGQLPKFQDGDLtLyQsNtILRHLGRTLGLYGKDQ |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P09874 | T397 | Sugiyama | PARP1 ADPRT PPOL | PAAVNSsAsADKPLSNMKILtLGKLSRNKDEVKAMIEKLGG |
| P09923 | T178 | Sugiyama | ALPI | AGKSVGVVTTTRVQHAsPAGtyAHtVNRNWysDADMPASAR |
| P09923 | T182 | Sugiyama | ALPI | VGVVTTTRVQHAsPAGtyAHtVNRNWysDADMPASARQEGC |
| P09972 | T123 | Sugiyama | ALDOC ALDC | IVVGIKVDKGVVPLAGtDGEtttQGLDGLsERCAQYKKDGA |
| P09972 | T124 | Sugiyama | ALDOC ALDC | VVGIKVDKGVVPLAGtDGEtttQGLDGLsERCAQYKKDGAD |
| P09972 | T125 | Sugiyama | ALDOC ALDC | VGIKVDKGVVPLAGtDGEtttQGLDGLsERCAQYKKDGADF |
| P0DPH7 | S48 | Sugiyama | TUBA3C TUBA2 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P0DPH7 | T51 | Sugiyama | TUBA3C TUBA2 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P10412 | S58 | Sugiyama | H1-4 H1F4 HIST1H1E | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P10809 | S488 | Sugiyama | HSPD1 HSP60 | IKRTLKIPAMtIAKNAGVEGsLIVEKIMQSSsEVGYDAMAG |
| P10809 | T206 | Sugiyama | HSPD1 HSP60 | IsDAMKKVGRKGVITVKDGKtLNDELEIIEGMKFDRGyIsP |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11586 | T128 | Sugiyama | MTHFD1 MTHFC MTHFD | SINTEEVINAIAPEKDVDGLtsINAGKLARGDLNDCFIPCt |
| P12268 | S505 | Sugiyama | IMPDH2 IMPD2 | SGELKFEKRtssAQVEGGVHsLHsyEKRLF___________ |
| P12814 | T709 | Sugiyama | ACTN1 | EGDHQLIQEALIFDNKHtNytMEHIRVGWEQLLTTIARTIN |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | T34 | Sugiyama | EEF2 EF2 | DKKANIRNMsVIAHVDHGKStLtDsLVCKAGIIAsARAGEt |
| P13639 | T484 | Sugiyama | EEF2 EF2 | VPCGNIVGLVGVDQFLVKtGtIttFEHAHNMRVMKFsVsPV |
| P13667 | S379 | Sugiyama | PDIA4 ERP70 ERP72 | QPEKFQSKYEPRSHMMDVQGstQDsAIKDFVLKyALPLVGH |
| P13667 | T139 | Sugiyama | PDIA4 ERP70 ERP72 | KIDAtsAsVLAsRFDVsGyPtIKILKKGQAVDyEGsRtQEE |
| P13667 | T497 | Sugiyama | PDIA4 ERP70 ERP72 | AILDEsGKKFAMEPEEFDsDtLREFVtAFKKGKLKPVIKSQ |
| P13674 | T140 | Sugiyama | P4HA1 P4HA | YFPNDEDQVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKS |
| P13674 | T147 | Sugiyama | P4HA1 P4HA | QVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKSFLTAEDC |
| P13987 | T76 | Sugiyama | CD59 MIC11 MIN1 MIN2 MIN3 MSK21 | AGLQVYNKCWKFEHCNFNDVtTRLRENELtyyCCKKDLCNF |
| P14618 | S77 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sVEtLKEMIKsGMNVARLNFsHGtHEyHAEtIKNVRtAtEs |
| P14618 | T80 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | tLKEMIKsGMNVARLNFsHGtHEyHAEtIKNVRtAtEsFAs |
| P14618 | T87 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sGMNVARLNFsHGtHEyHAEtIKNVRtAtEsFAsDPILyRP |
| P14625 | S523 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | RtRLAKLLRFQssHHPtDItsLDQyVERMKEKQDKIyFMAG |
| P15311 | T299 | Sugiyama | EZR VIL2 | RILQLCMGNHELYMRRRKPDtIEVQQMKAQAREEKHQKQLE |
| P15531 | S122 | Sugiyama | NME1 NDPKA NM23 | GtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDy |
| P15880 | T230 | Sugiyama | RPS2 RPS4 | PKKLLMMAGIDDCytsARGCtAtLGNFAKATFDAISKTysy |
| P15880 | T232 | Sugiyama | RPS2 RPS4 | KLLMMAGIDDCytsARGCtAtLGNFAKATFDAISKTysyLt |
| P16083 | S80 | Sugiyama | NQO2 NMOR2 | LSNPEVFNyGVEtHEAyKQRsLAsDITDEQKKVREADLVIF |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16402 | S59 | Sugiyama | H1-3 H1F3 HIST1H1D | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | S58 | Sugiyama | H1-2 H1F2 HIST1H1C | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P17066 | T228 | Sugiyama | HSPA6 HSP70B' | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P17812 | T566 | Sugiyama | CTPS1 CTPS | ASVGRLSHYLQKGCRLsPRDtysDRsGsssPDsEItELKFP |
| P17844 | S520 | Sugiyama | DDX5 G17P1 HELR HLR1 | GKRGGFNTFRDRENYDRGYssLLKRDFGAKTQNGVYSAANY |
| P19174 | S672 | Sugiyama | PLCG1 PLC1 | RLSEPVPQTNAHESKEWYHAsLTRAQAEHMLMRVPRDGAFL |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P20290 | T131 | Sugiyama | BTF3 NACB OK/SW-cl.8 | NQGTVIHFNNPKVQAsLAANtFtItGHAEtKQLTEMLPsIL |
| P20290 | T133 | Sugiyama | BTF3 NACB OK/SW-cl.8 | GTVIHFNNPKVQAsLAANtFtItGHAEtKQLTEMLPsILNQ |
| P20674 | T105 | Sugiyama | COX5A | EPKIIDAALRACRRLNDFAstVRILEVVKDKAGPHKEIYPY |
| P22090 | S204 | Sugiyama | RPS4Y1 RPS4Y PRO2646 | IGGANLGRVGVITNRERHPGsFDVVHVKDANGNSFATRLSN |
| P22314 | T676 | Sugiyama | UBA1 A1S9T UBE1 | FKQPAENVNQyLtDPKFVERtLRLAGtQPLEVLEAVQRSLV |
| P23246 | S283 | Sugiyama | SFPQ PSF | GPGGRsEEKIsDsEGFKANLsLLRRPGEKTyTQRCRLFVGN |
| P23381 | T383 | Sugiyama | WARS1 IFI53 WARS WRS | DtAKQIKTKVNKHAFsGGRDtIEEHRQFGGNCDVDVSFMYL |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P24752 | T220 | Sugiyama | ACAT1 ACAT MAT | TAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNEVIPVtV |
| P25205 | S704 | Sugiyama | MCM3 | DQEQKRKRRKTRQPDAKDGDsyDPyDFsDtEEEMPQVHtPK |
| P26038 | T299 | Sugiyama | MSN | RILALCMGNHELYMRRRKPDtIEVQQMKAQAREEKHQKQME |
| P26038 | T526 | Sugiyama | MSN | EERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHA |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26447 | T15 | Sugiyama | S100A4 CAPL MTS1 | ______MACPLEKALDVMVstFHKYSGKEGDKFKLNKSELK |
| P26639 | T700 | Sugiyama | TARS1 TARS | EKISGTVNIRTRDNKVHGERtIsEtIERLQQLKEFRSKQAE |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P26641 | T302 | Sugiyama | EEF1G EF1G PRO1608 | HLPKstFVLDEFKRKysNEDtLsVALPyFWEHFDKDGWSLW |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P29401 | S295 | Sugiyama | TKT | ysQIQsKKKILAtPPQEDAPsVDIANIRMPsLPsyKVGDKI |
| P29401 | T346 | Sugiyama | TKT | AKLGHAsDRIIALDGDtKNstFsEIFKKEHPDRFIECYIAE |
| P29401 | T442 | Sugiyama | TKT | GEDGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAA |
| P30086 | S60 | Sugiyama | PEBP1 PBP PEBP | VLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPK |
| P30086 | T65 | Sugiyama | PEBP1 PBP PEBP | QVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREWH |
| P30101 | S155 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | ASVPLRTEEEFKKFISDKDAsIVGFFDDsFsEAHsEFLKAA |
| P31327 | S1261 | Sugiyama | CPS1 | NVQFLVKGNDVLVIECNLRAsRSFPFVsKTLGVDFIDVATK |
| P31327 | S1268 | Sugiyama | CPS1 | GNDVLVIECNLRAsRSFPFVsKTLGVDFIDVATKVMIGENV |
| P31327 | T45 | Sugiyama | CPS1 | AHQKWKFSRPGIRLLSVKAQtAHIVLEDGtKMKGYSFGHPS |
| P31942 | S298 | Sugiyama | HNRNPH3 HNRPH3 | GGsGMGGYGRDGMDNQGGyGsVGRMGMGNNysGGyGtPDGL |
| P31943 | S285 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | NyCFsGMsDHRyGDGGstFQsttGHCVHMRGLPYRAtENDI |
| P31943 | T282 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | RDLNyCFsGMsDHRyGDGGstFQsttGHCVHMRGLPYRAtE |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P31948 | S16 | Sugiyama | STIP1 | _____MEQVNELKEKGNKALsVGNIDDALQCysEAIKLDPH |
| P31948 | T145 | Sugiyama | STIP1 | MNPFNMPNLYQKLESDPRtRtLLSDPTYRELIEQLRNKPSD |
| P31948 | T243 | Sugiyama | STIP1 | KQALKEKELGNDAYKKKDFDtALKHYDKAKELDPtNMtyIT |
| P31949 | T33 | Sugiyama | S100A11 MLN70 S100C | CIESLIAVFQKYAGKDGyNytLsKtEFLsFMNTELAAFTKN |
| P34931 | T228 | Sugiyama | HSPA1L | DVSILTIDDGIFEVKAtAGDtHLGGEDFDNRLVsHFVEEFK |
| P34932 | T758 | Sugiyama | HSPA4 APG2 HSPH2 | TNEAMEWMNNKLNLQNKQsLtMDPVVKSKEIEAKIKELTst |
| P35241 | T299 | Sugiyama | RDX | RILALCMGNHELYMRRRKPDtIEVQQMKAQAREEKHQKQLE |
| P35268 | T62 | Sugiyama | RPL22 | FLQERIKVNGKAGNLGGGVVtIERsKSKITVTSEVPFSKRY |
| P35269 | T154 | Sugiyama | GTF2F1 RAP74 | AFEAFPVHNWYNFTPLARHRtLtAEEAEEEWERRNKVLNHF |
| P35269 | T41 | Sugiyama | GTF2F1 RAP74 | NTTKKyNIMAFNAADKVNFAtWNQARLERDLSNKKIyQEEE |
| P35354 | S448 | Sugiyama | PTGS2 COX2 | PAVQKVSQASIDQSRQMKyQsFNEYRKRFMLKPYESFEELT |
| P35609 | T716 | Sugiyama | ACTN2 | EGDHQLIQEALVFDNKHtNytMEHIRVGWELLLTTIARTIN |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | T271 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DISILEIQKGVFEVKSTNGDtFLGGEDFDQALLRHIVKEFK |
| P38646 | T86 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | CVAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAK |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P43034 | S152 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | IKVWDyEtGDFERtLKGHtDsVQDIsFDHsGKLLASCSADM |
| P43121 | T100 | Sugiyama | MCAM MUC18 | QGQSEPGEYEQRLsLQDRGAtLALtQVtPQDERIFLCQGKR |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P46060 | S24 | Sugiyama | RANGAP1 KIAA1835 SD | EDIAKLAETLAKTQVAGGQLsFKGKSLKLNTAEDAKDVIKE |
| P46734 | S218 | SIGNOR | MAP2K3 MEK3 MKK3 PRKMK3 SKK2 | INKEGHVKMCDFGISGyLVDsVAKtMDAGCKPYMAPERINP |
| P46777 | S172 | Sugiyama | RPL5 MSTP030 | RTTTGNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNA |
| P46940 | T1471 | Sugiyama | IQGAP1 KIAA0051 | tLQEKKEKIQTGLKKLTELGtVDPKNKyQELINDIARDIRN |
| P48739 | S165 | Sugiyama | PITPNB | DRSQVEPADyKADEDPALFQsVKtKRGPLGPNWKKELANsP |
| P48741 | T228 | Sugiyama | HSPA7 HSP70B | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P49327 | T1999 | Sugiyama | FASN FAS | LLENQTPEFFQDVCKPKYsGtLNLDRVTREACPELDYFVVF |
| P49327 | T262 | Sugiyama | FASN FAS | VYATILNAGTNTDGFKEQGVtFPsGDIQEQLIRSLyQsAGV |
| P49368 | T373 | Sugiyama | CCT3 CCTG TRIC5 | KKIGDEYFTFITDCKDPKACtILLRGAsKEILSEVERNLQD |
| P49368 | T459 | Sugiyama | CCT3 CCTG TRIC5 | AVAQALEVIPRTLIQNCGAstIRLLtSLRAKHtQENCEtWG |
| P49411 | T433 | Sugiyama | TUFM | LRQPMILEKGQRFTLRDGNRtIGTGLVTNTLAMTEEEKNIK |
| P50990 | T398 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | RGstDNLMDDIERAVDDGVNtFKVLTRDKRLVPGGGAtEIE |
| P51149 | T168 | Sugiyama | RAB7A RAB7 | NIPyFEtSAKEAINVEQAFQtIARNALKQETEVELyNEFPE |
| P51659 | T191 | Sugiyama | HSD17B4 EDH17B4 SDR8C1 | LLGLANSLAIEGRKsNIHCNtIAPNAGsRMTQTVMPEDLVE |
| P52565 | S148 | Sugiyama | ARHGDIA GDIA1 | YIQHTyRKGVKIDKtDyMVGsYGPRAEEyEFLtPVEEAPKG |
| P52888 | S133 | Sugiyama | THOP1 | SMREDVYQRIVWLQEKVQKDsLRPEAARYLERLIKLGRRNG |
| P52948 | S683 | Sugiyama | NUP98 ADAR2 | IAKPIPQtPEsAGNKHsNsNsVDDtIVALNMRAALRNGLEG |
| P53621 | T821 | Sugiyama | COPA | IMPLDTNWPLLTVSKGFFEGtIAsKGKGGALAADIDIDTVG |
| P54577 | T130 | Sugiyama | YARS1 YARS | VPLEKLKFIKGTDYQLSKEytLDVyRLSSVVTQHDSKKAGA |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P54868 | T133 | Sugiyama | HMGCS2 | LMERIQLPWDSVGRLEVGTEtIIDKSKAVKTVLMELFQDSG |
| P55010 | T227 | Sugiyama | EIF5 | ttEEAQRRRMDEISDHAKVLtLsDDLERtIEERVNILFDFV |
| P55060 | S931 | Sugiyama | CSE1L CAS XPO2 | KKEHDPVGQMVNNPKIHLAQsLHKLSTACPGRVPSMVSTSL |
| P55209 | S69 | Sugiyama | NAP1L1 NRP | LAALQERLDGLVEtPtGyIEsLPRVVKRRVNALKNLQVKCA |
| P55854 | S27 | Sugiyama | SUMO3 SMT3A SMT3H1 | KEGVKTENDHINLKVAGQDGsVVQFKIKRHTPLSKLMKAYC |
| P56192 | S127 | Sugiyama | MARS1 MARS | GKKGEDVLGSVRRALTHIDHsLSRQNCPFLAGETESLADIV |
| P57721 | S59 | Sugiyama | PCBP3 PCBP3-OT1 PCBP3OT | EGGLNVTLTIRLLMHGKEVGsIIGKKGETVKKMREESGARI |
| P57723 | S31 | Sugiyama | PCBP4 | EPELSITLTLRMLMHGKEVGsIIGKKGETVKRIREQSSARI |
| P60174 | S236 | Sugiyama | TPI1 TPI | AtCKELASQPDVDGFLVGGAsLKPEFVDIINAKQ_______ |
| P60174 | T176 | Sugiyama | TPI1 TPI | KDWSKVVLAyEPVWAIGtGKtATPQQAQEVHEKLRGWLKsN |
| P60174 | T90 | Sugiyama | TPI1 TPI | VTNGAFtGEIsPGMIKDCGAtWVVLGHsERRHVFGEsDELI |
| P60660 | T103 | Sugiyama | MYL6 | QGtyEDyVEGLRVFDKEGNGtVMGAEIRHVLVtLGEKMTEE |
| P60660 | T22 | Sugiyama | MYL6 | CDFTEDQTAEFKEAFQLFDRtGDGKILysQCGDVMRALGQN |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | T202 | Sugiyama | ACTB | GRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALD |
| P60709 | T249 | Sugiyama | ACTB | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P61163 | T248 | Sugiyama | ACTR1A CTRN1 | PQKDETLETEKAQyyLPDGstIEIGPSRFRAPELLFRPDLI |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P61513 | Y14 | Sugiyama | RPL37A | _______MAKRTKKVGIVGKyGtRYGAsLRKMVKKIEISQH |
| P61587 | S210 | PSP | RND3 ARHE RHO8 RHOE | FHVATLACVNKTNKNVKRNKsQRATKRIsHMPSRPELSAVA |
| P61587 | S218 | PSP | RND3 ARHE RHO8 RHOE | VNKTNKNVKRNKsQRATKRIsHMPSRPELSAVATDLRKDKA |
| P61587 | S240 | PSP | RND3 ARHE RHO8 RHOE | MPSRPELSAVATDLRKDKAKsCTVM________________ |
| P61769 | S75 | Sugiyama | B2M CDABP0092 HDCMA22P | IEVDLLKNGERIEKVEHsDLsFsKDWSFYLLYYTEFTPTEK |
| P61916 | T106 | Sugiyama | NPC2 HE1 | PIPEPDGCKSGINCPIQKDKtySYLNKLPVKSEYPSIKLVV |
| P61956 | S28 | Sugiyama | SUMO2 SMT3B SMT3H2 | EGVKtENNDHINLKVAGQDGsVVQFKIKRHTPLSKLMKAYC |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P62081 | T172 | Sugiyama | RPS7 | RLIKVHLDKAQQNNVEHKVEtFsGVyKKLTGKDVNFEFPEF |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62263 | S139 | Sugiyama | RPS14 PRO2640 | LARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL________ |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62280 | T54 | Sugiyama | RPS11 | PRYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILs |
| P62424 | T84 | Sugiyama | RPL7A SURF-3 SURF3 | QRQRAILyKRLKVPPAINQFtQALDRQTAtQLLKLAHKYRP |
| P62701 | S204 | Sugiyama | RPS4X CCG2 RPS4 SCAR | tGGANLGRIGVITNRERHPGsFDVVHVKDANGNSFATRLsN |
| P62701 | T247 | Sugiyama | RPS4X CCG2 RPS4 SCAR | VIGKGNKPWIsLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | T251 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62750 | T126 | Sugiyama | RPL23A | KHQIKQAVKKLyDIDVAKVNtLIRPDGEKKAYVRLAPDyDA |
| P62826 | S135 | Sugiyama | RAN ARA24 OK/SW-cl.81 | IPIVLCGNKVDIKDRKVKAKsIVFHRKKNLQyyDIsAKSNy |
| P62826 | T21 | Sugiyama | RAN ARA24 OK/SW-cl.81 | MAAQGEPQVQFKLVLVGDGGtGKttFVKRHLtGEFEKKyVA |
| P62906 | T9 | Sugiyama | RPL10A NEDD6 | ____________MSSKVsRDtLyEAVREVLHGNQRKRRKFL |
| P62917 | S14 | Sugiyama | RPL8 | _______MGRVIRGQRKGAGsVFRAHVKHRKGAARLRAVDF |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62942 | T22 | Sugiyama | FKBP1A FKBP1 FKBP12 | GVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRD |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63220 | S68 | Sugiyama | RPS21 | GQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF_____ |
| P63241 | S100 | Sugiyama | EIF5A | DVPNIKRNDFQLIGIQDGyLsLLQDSGEVREDLRLPEGDLG |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | T202 | Sugiyama | ACTG1 ACTG | GRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALD |
| P63261 | T249 | Sugiyama | ACTG1 ACTG | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | T250 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | T251 | Sugiyama | ACTC1 ACTC | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68104 | S21 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | MGKEKtHINIVVIGHVDsGKstttGHLIyKCGGIDKRTIEK |
| P68104 | T22 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | GKEKtHINIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKF |
| P68104 | T261 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| P68104 | T432 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | T251 | Sugiyama | ACTA1 ACTA | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | S48 | Sugiyama | TUBA1B | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P68363 | T51 | Sugiyama | TUBA1B | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P68363 | T80 | Sugiyama | TUBA1B | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| P68363 | Y83 | Sugiyama | TUBA1B | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| P68431 | T46 | Sugiyama | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| P78406 | T256 | Sugiyama | RAE1 MRNP41 | IEGRVAIHYINPPNPAKDNFtFKCHRSNGTNTSAPQDIyAV |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| P84243 | T46 | Sugiyama | H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B | ARKsAPsTGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q00341 | T729 | Sugiyama | HDLBP HBP VGL | VEKAKKQLLHLAEEKQTKSFtVDIRAKPEYHKFLIGKGGGK |
| Q00610 | T875 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | LKLLLPWLEARIHEGCEEPAtHNALAKIyIDsNNNPERFLR |
| Q00796 | S73 | Sugiyama | SORD | EYGRIGNFIVKKPMVLGHEAsGtVEKVGSSVKHLKPGDRVA |
| Q01105 | S168 | Sugiyama | SET | ENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQN |
| Q01130 | S208 | Sugiyama | SRSF2 SFRS2 | RsRsPPPVsKRESKSRSRsKsPPKsPEEEGAVss_______ |
| Q01581 | T96 | Sugiyama | HMGCS1 HMGCS | LMERNNLsyDCIGRLEVGTEtIIDKSKSVKTNLMQLFEESG |
| Q01844 | S443 | Sugiyama | EWSR1 EWS | AKAAVEWFDGKDFQGSKLKVsLARKKPPMNSMRGGLPPREG |
| Q04917 | S145 | Sugiyama | YWHAH YWHA1 | KMKGDYYRYLAEVASGEKKNsVVEAsEAAyKEAFEISKEQM |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q05639 | S21 | Sugiyama | EEF1A2 EEF1AL STN | MGKEKtHINIVVIGHVDsGKstttGHLIyKCGGIDKRTIEK |
| Q05639 | T22 | Sugiyama | EEF1A2 EEF1AL STN | GKEKtHINIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKF |
| Q05639 | T261 | Sugiyama | EEF1A2 EEF1AL STN | PTDKPLRLPLQDVyKIGGIGtVPVGRVETGILRPGMVVTFA |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q06830 | T183 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | FQFtDKHGEVCPAGWKPGsDtIKPDVQKSKEyFSKQK____ |
| Q07020 | T136 | Sugiyama | RPL18 | AGGKILtFDQLALDsPKGCGtVLLsGPRKGREVYRHFGKAP |
| Q07020 | T85 | Sugiyama | RPL18 | RMIRKMKLPGRENKtAVVVGtItDDVRVQEVPKLKVCALRV |
| Q07666 | S20 | Sugiyama | KHDRBS1 SAM68 | _MQRRDDPAARMsRssGRsGsMDPsGAHPsVRQtPsRQPPL |
| Q07666 | T183 | Sugiyama | KHDRBS1 SAM68 | PVKQYPKFNFVGKILGPQGNtIKRLQEETGAKISVLGKGsM |
| Q08AD1 | T469 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | SVQRstPNRGITRsIsNEGLtLNNsHVsKHIRKNLSFKPIN |
| Q08J23 | T276 | Sugiyama | NSUN2 SAKI TRM4 | RKEILFyDRILCDVPCSGDGtMRKNIDVWKKWTTLNSLQLH |
| Q12931 | T494 | Sugiyama | TRAP1 HSP75 HSPC5 | ALPsGQLtsLsEyASRMRAGtRNIyyLCAPNRHLAEHsPyy |
| Q13283 | S232 | Sugiyama | G3BP1 G3BP | EEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsWA |
| Q13283 | S67 | Sugiyama | G3BP1 G3BP | sNGKPADAVyGQKEIHRKVMsQNFtNCHTKIRHVDAHATLN |
| Q13283 | T241 | Sugiyama | G3BP1 G3BP | ETAPEDAQKsssPAPADIAQtVQEDLRtFsWAsVtsKNLPP |
| Q13509 | S75 | Sugiyama | TUBB3 TUBB4 | SSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIFGQS |
| Q13561 | T315 | Sugiyama | DCTN2 DCTN50 | KHKASVEDADTQSKVHQLyEtIQRWsPIASTLPELVQRLVT |
| Q13885 | S75 | Sugiyama | TUBB2A TUBB2 | AGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q14103 | T91 | Sugiyama | HNRNPD AUF1 HNRPD | sKNEEDEGHsNssPRHsEAAtAQREEWKMFIGGLSWDTTKK |
| Q14152 | S1188 | Sugiyama | EIF3A EIF3S10 KIAA0139 | PWRPLVKPGGWREKEKAREEsWGPPRESRPsEEREWDREKE |
| Q14152 | S1258 | Sugiyama | EIF3A EIF3S10 KIAA0139 | RFRRPRDEGGWRRGPAEEsssWRDssRRDDRDRDDRRRERD |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14152 | T1379 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EKDREsLRRTKNEtDEDGWttVRR_________________ |
| Q14203 | T509 | Sugiyama | DCTN1 | LDMAGARVREAQKRVEAAQEtVADyQQTIKKYRQLtAHLQD |
| Q14203 | Y513 | Sugiyama | DCTN1 | GARVREAQKRVEAAQEtVADyQQTIKKYRQLtAHLQDVNRE |
| Q14247 | T68 | Sugiyama | CTTN EMS1 | GHQEHINIHKLRENVFQEHQtLKEKELETGPKASHGyGGKF |
| Q14498 | S117 | Sugiyama | RBM39 HCC1 RNPC2 | sPysGPKFNSAIRGKIGLPHsIKLsRRRSRSKSPFRKDKsP |
| Q14568 | S169 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | TVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTKVILH |
| Q14568 | T109 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LTIVDTGIGMTKADLINNLGtIAKSGtKAFMEALQAGADIS |
| Q14568 | T171 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | ITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTKVILHLK |
| Q14697 | S52 | Sugiyama | GANAB G2AN KIAA0088 | AVDRSNFKtCEEssFCKRQRsIRPGLsPyRALLDSLQLGPD |
| Q14974 | T860 | Sugiyama | KPNB1 NTF97 | RPMIHELLTEGRRSKTNKAKtLAtWATKELRKLKNQA____ |
| Q14974 | T863 | Sugiyama | KPNB1 NTF97 | IHELLTEGRRSKTNKAKtLAtWATKELRKLKNQA_______ |
| Q15084 | S169 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | GKQGRSDsSSKKDVIELtDDsFDKNVLDSEDVWMVEFYAPW |
| Q15185 | S72 | Sugiyama | PTGES3 P23 TEBP | EIDLFHCIDPNDsKHKRtDRsILCCLRKGEsGQsWPRLTKE |
| Q15185 | S85 | Sugiyama | PTGES3 P23 TEBP | KHKRtDRsILCCLRKGEsGQsWPRLTKERAKLNWLsVDFNN |
| Q15365 | S27 | Sugiyama | PCBP1 | ESGLNVTLTIRLLMHGKEVGsIIGKKGESVKRIREEsGARI |
| Q15366 | S27 | Sugiyama | PCBP2 | EGGLNVTLTIRLLMHGKEVGsIIGKKGESVKKMREESGARI |
| Q15369 | T41 | Sugiyama | ELOC TCEB1 | LISSDGHEFIVKREHALtsGtIKAMLSGPGQFAENETNEVN |
| Q15459 | S508 | Sugiyama | SF3A1 SAP114 | IGEEEIQKPEEKVTWDGHsGsMARTQQAAQANITLQEQIEA |
| Q15758 | T532 | Sugiyama | SLC1A5 ASCT2 M7V1 RDR RDRC | VPTEEGNPLLKHyRGPAGDAtVAsEKEsVM___________ |
| Q16181 | T426 | PSP | SEPTIN7 CDC10 SEPT7 | DEKANWEAQQRILEQQNssRtLEKNKKKGKIF_________ |
| Q16658 | T239 | Sugiyama | FSCN1 FAN1 HSN SNL | GKVAFRDCEGRyLAPsGPsGtLKAGKATKVGKDELFALEQs |
| Q16695 | T46 | Sugiyama | H3-4 H3FT HIST3H3 | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q16775 | T291 | Sugiyama | HAGH GLO2 HAGH1 | PFMRVREKTVQQHAGETDPVttMRAVRREKDQFKMPRD___ |
| Q16775 | T292 | Sugiyama | HAGH GLO2 HAGH1 | FMRVREKTVQQHAGETDPVttMRAVRREKDQFKMPRD____ |
| Q4V328 | S666 | Sugiyama | GRIPAP1 KIAA1167 | EELVLsEMNsPSRtQtGDsssIssFsYREILREKEssAVPA |
| Q562R1 | T250 | Sugiyama | ACTBL2 | RAAAssSPERsyELPDGQVItIGNERFRCPEAIFQPSFLGI |
| Q58FF8 | T104 | Sugiyama | HSP90AB2P HSP90BB | LTLVDTGIGMTKADLINNLGtIAKFQDQTEYLEEMQVKEVV |
| Q5SSJ5 | S225 | Sugiyama | HP1BP3 | QALKRELNRGVIKQVKGKGAsGsFVVVQKSRKTPQKSRNRK |
| Q5VTE0 | S21 | Sugiyama | EEF1A1P5 EEF1AL3 | MGKEKtHINIVVIGHVDsGKstttGHLIyKCGGIDKRTIEK |
| Q5VTE0 | T22 | Sugiyama | EEF1A1P5 EEF1AL3 | GKEKtHINIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKF |
| Q5VTE0 | T261 | Sugiyama | EEF1A1P5 EEF1AL3 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q6EEV6 | S28 | Sugiyama | SUMO4 SMT3H4 | EEVKTENNNHINLKVAGQDGsVVQFKIKRQTPLSKLMKAYC |
| Q6NXT2 | T45 | Sugiyama | H3-5 H3F3C | AARKSTPSTCGVKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q6PEY2 | S48 | Sugiyama | TUBA3E | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q6PEY2 | T51 | Sugiyama | TUBA3E | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q6S8J3 | T949 | Sugiyama | POTEE A26C1A POTE2 | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q71DI3 | T46 | Sugiyama | H3C15 HIST2H3A; H3C14 H3F2 H3FM HIST2H3C; H3C13 HIST2H3D | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q71U36 | S48 | Sugiyama | TUBA1A TUBA3 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q71U36 | T51 | Sugiyama | TUBA1A TUBA3 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q71U36 | T80 | Sugiyama | TUBA1A TUBA3 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q71U36 | Y83 | Sugiyama | TUBA1A TUBA3 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q7KZI7 | T208 | SIGNOR | MARK2 EMK1 | NIKIADFGFSNEFTFGNKLDtFCGsPPYAAPELFQGKKYDG |
| Q7RTP6 | S1998 | Sugiyama | MICAL3 KIAA0819 KIAA1364 | RLREREEDKDLEAAMLSKGFsLNWS________________ |
| Q7RTV0 | S53 | Sugiyama | PHF5A | CDSyVRPCTLVRICDECNyGsyQGRCVICGGPGVSDAyyCK |
| Q7Z417 | S652 | Sugiyama | NUFIP2 KIAA1321 PIG1 | NtLLGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsI |
| Q7Z4V5 | S454 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | VRPEEKQQAKPVKVERTRKRsEGFsMDRKVEKKKEPSVEEK |
| Q86V81 | T148 | Sugiyama | ALYREF ALY BEF THOC4 | EFGtLKKAAVHYDRsGRsLGtADVHFERKADALKAMKQYNG |
| Q86XZ4 | T192 | Sugiyama | SPATS2 SCR59 SPATA10 Nbla00526 | LDRTGSMLQNGVSDFETKsLtMHSIHNSQQPRNAAKsLsRP |
| Q8N1F7 | T121 | Sugiyama | NUP93 KIAA0095 | FLKNEKDNALLsAIEESRKRtFGMAEEYHRESMLVEWEQVK |
| Q8N680 | T264 | Sugiyama | ZBTB2 KIAA1483 ZNF437 | MKRNGSFPKYYACHLCGRRFtLRSSLREHLQIHTGVPFTSS |
| Q8TD47 | T247 | Sugiyama | RPS4Y2 RPS4Y2P | VIGNGNKPWISLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| Q92598 | S65 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | NRTIGVAAKNQQITHANNtVsNFKRFHGRAFNDPFIQKEKE |
| Q92598 | T63 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | SKNRTIGVAAKNQQITHANNtVsNFKRFHGRAFNDPFIQKE |
| Q93052 | T325 | Sugiyama | LPP | PGyGGRNDsDPtyGQQGHPNtWKREPGytPPGAGNQNPPGM |
| Q96D15 | T124 | Sugiyama | RCN3 UNQ239/PRO272 | AWIAHTQQRHIRDsVsAAWDtyDtDRDGRVGWEELRNATYG |
| Q96QK1 | T773 | Sugiyama | VPS35 MEM3 TCCCTA00141 | DLPNLEssEEtEQINKHFHNtLEHLRLRREsPEsEGPIyEG |
| Q99426 | T120 | Sugiyama | TBCB CG22 CKAP1 | DVSRVEKytIsQEAyDQRQDtVRSFLKRsKLGRyNEEERAQ |
| Q99497 | T140 | Sugiyama | PARK7 | GSKVTtHPLAKDKMMNGGHytysENRVEKDGLILtSRGPGT |
| Q99497 | Y139 | Sugiyama | PARK7 | FGSKVTtHPLAKDKMMNGGHytysENRVEKDGLILtSRGPG |
| Q99584 | S32 | Sugiyama | S100A13 | SIETVVTTFFTFARQEGRKDsLsVNEFKELVTQQLPHLLKD |
| Q99584 | S62 | Sugiyama | S100A13 | VTQQLPHLLKDVGSLDEKMKsLDVNQDSELKFNEyWRLIGE |
| Q99613 | T880 | Sugiyama | EIF3C EIF3S8 | AEKLGsLVENNERVFDHKQGtyGGyFRDQKDGYRKNEGYMR |
| Q99832 | T98 | Sugiyama | CCT7 CCTH NIP7-1 | TLVDIAKSQDAEVGDGTTsVtLLAAEFLKQVKPYVEEGLHP |
| Q9BQE3 | S48 | Sugiyama | TUBA1C TUBA6 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q9BQE3 | T51 | Sugiyama | TUBA1C TUBA6 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q9BQE3 | T80 | Sugiyama | TUBA1C TUBA6 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q9BQE3 | Y83 | Sugiyama | TUBA1C TUBA6 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q9BS26 | T293 | Sugiyama | ERP44 KIAA0573 TXNDC4 UNQ532/PRO1075 | TESLEIFQNEVARQLISEKGtINFLHADCDKFRHPLLHIQK |
| Q9BUJ2 | S512 | Sugiyama | HNRNPUL1 E1BAP5 HNRPUL1 | IQIAARKKRNyILDQtNVyGsAQRRKMRPFEGFQRKAIVIC |
| Q9BVA1 | S75 | Sugiyama | TUBB2B | tGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q9BYX7 | T249 | Sugiyama | POTEKP ACTBL3 FKSG30 | MAASSSSVEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q9H173 | T125 | Sugiyama | SIL1 UNQ545/PRO836 | QYEDKFRNNLKGKRLDINtNtytsQDLKSALAKFKEGAEME |
| Q9H4A3 | T2245 | Sugiyama | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | TVNSQAAQAQPPAMTSSRKGtFtDDLHKLVDNWARDAMNLS |
| Q9H4A3 | T2247 | Sugiyama | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | NSQAAQAQPPAMTSSRKGtFtDDLHKLVDNWARDAMNLSGR |
| Q9HB71 | T209 | Sugiyama | CACYBP S100A6BP SIP PNAS-107 | EGLMNVLKKIyEDGDDDMKRtINKAWVESREKQAKGDTEF_ |
| Q9HCN8 | T196 | Sugiyama | SDF2L1 UNQ1941/PRO4424 | EQYGSPIRGQHEVHGMPSANtHNtWKAMEGIFIKPSVEPSA |
| Q9HCN8 | T199 | Sugiyama | SDF2L1 UNQ1941/PRO4424 | GSPIRGQHEVHGMPSANtHNtWKAMEGIFIKPSVEPSAGHD |
| Q9NSE4 | T1000 | Sugiyama | IARS2 | MPTTKEKCPRCWKYTAESSDtLCPRCAEVVSGK________ |
| Q9P0J1 | T494 | Sugiyama | PDP1 PDP PPM2C | EDQNAATHLIRHAVGNNEFGtVDHERLSKMLSLPEELARMY |
| Q9P0L2 | T215 | iPTMNet|EPSD | MARK1 KIAA1477 MARK | NIKIADFGFSNEFTVGNKLDtFCGsPPYAAPELFQGKKYDG |
| Q9P2B2 | T497 | Sugiyama | PTGFRN CD9P1 EWIF FPRP KIAA1436 | ERSKQRAQDGDFIFSKEHTDtFNFRIQRTTEEDRGNyyCVV |
| Q9UBQ5 | T28 | Sugiyama | EIF3K EIF3S12 ARG134 HSPC029 MSTP001 PTD001 | RANVGKLLKGIDRyNPENLAtLERYVETQAKENAyDLEANL |
| Q9UGV2 | S331 | Sugiyama | NDRG3 | QGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQ |
| Q9UGV2 | T332 | Sugiyama | NDRG3 | GMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQs |
| Q9UII2 | S39 | Sugiyama | ATP5IF1 ATPI ATPIF1 | TMQARGFGsDQSENVDRGAGsIREAGGAFGKREQAEEERyF |
| Q9UJW0 | T141 | Sugiyama | DCTN4 | VGMADKSVASGGWQEPENPHtQRMNKLIEyyQQLAQKEKVE |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
| Q9UQ35 | S1648 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | APRALPRRSRSGSSSKGRGPsPEGssstEssPEHPPKSRTA |
| Q9UQ35 | S2692 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ERRSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQS |
| Q9UQ35 | T2034 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | TRRRSRsRtPPAIRRRsRsRtPLLPRKRsRsRsPLAIRRRS |
| Q9UQ80 | T200 | Sugiyama | PA2G4 EBP1 | TPIEGMLSHQLKQHVIDGEKtIIQNPTDQQKKDHEKAEFEV |
| Q9Y2B0 | T100 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | ELLEEICDRMKEyGEQIDPstHRKNYVRVVGRNGEssELDL |
| Q9Y2V2 | S30 | Sugiyama | CARHSP1 | QPPtHQAsVGLLDtPRsRERsPsPLRGNVVPsPLPtRRtRt |
| Q9Y2V2 | S32 | Sugiyama | CARHSP1 | PtHQAsVGLLDtPRsRERsPsPLRGNVVPsPLPtRRtRtFs |
| Q9Y2V2 | S52 | Sugiyama | CARHSP1 | sPLRGNVVPsPLPtRRtRtFsAtVRASQGPVYKGVCKCFCR |
| Q9Y3S1 | T2157 | Sugiyama | WNK2 KIAA1760 PRKWNK2 SDCCAG43 P/OKcl.13 | GPQPALHVQAQVNNSNNKKGtFtDDLHKLVDEWTSKTVGAA |
| Q9Y3S1 | T2159 | Sugiyama | WNK2 KIAA1760 PRKWNK2 SDCCAG43 P/OKcl.13 | QPALHVQAQVNNSNNKKGtFtDDLHKLVDEWTSKTVGAAQL |
| Q9Y450 | S67 | Sugiyama | HBS1L HBS1 KIAA1038 | KPsVEPVEEyDyEDLKEssNsVsNHQLSGFDQARLYsCLDH |
| Q9Y5L4 | S57 | Sugiyama | TIMM13 TIM13B TIMM13A TIMM13B | ELLQRMTDKCFRKCIGKPGGsLDNSEQKCIAMCMDRyMDAW |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Signal Transduction | R-HSA-162582 | 4.473095e-09 | 8.349 | 1 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.474581e-08 | 7.831 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 6.308298e-08 | 7.200 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 9.467511e-08 | 7.024 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 5.575493e-07 | 6.254 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.076111e-06 | 5.512 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 3.312079e-06 | 5.480 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 4.248827e-06 | 5.372 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 4.555842e-06 | 5.341 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.117481e-06 | 5.291 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 6.987690e-06 | 5.156 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 9.281877e-06 | 5.032 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.459814e-05 | 4.836 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.133106e-05 | 4.671 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.594615e-05 | 4.586 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.555206e-05 | 4.593 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.962489e-05 | 4.528 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.692343e-05 | 4.433 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 5.164378e-05 | 4.287 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 5.630395e-05 | 4.249 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 5.913912e-05 | 4.228 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 7.897896e-05 | 4.102 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 9.503081e-05 | 4.022 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.211737e-04 | 3.917 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.292019e-04 | 3.889 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.292019e-04 | 3.889 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.292019e-04 | 3.889 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.292019e-04 | 3.889 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.293764e-04 | 3.888 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.522584e-04 | 3.817 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.938354e-04 | 3.713 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.176256e-04 | 3.662 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.509487e-04 | 3.455 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.394404e-04 | 3.469 | 0 | 0 |
| Immune System | R-HSA-168256 | 3.482283e-04 | 3.458 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 3.811211e-04 | 3.419 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 4.257970e-04 | 3.371 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.939529e-04 | 3.226 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 6.640670e-04 | 3.178 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 6.717369e-04 | 3.173 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 7.707708e-04 | 3.113 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 7.863202e-04 | 3.104 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 9.408371e-04 | 3.026 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 9.888325e-04 | 3.005 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 9.807611e-04 | 3.008 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.062345e-03 | 2.974 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.069844e-03 | 2.971 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.143898e-03 | 2.942 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.143898e-03 | 2.942 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.163079e-03 | 2.934 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.165452e-03 | 2.934 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 1.332646e-03 | 2.875 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.325570e-03 | 2.878 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.325570e-03 | 2.878 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.502702e-03 | 2.823 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.637205e-03 | 2.786 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.568308e-03 | 2.805 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.770438e-03 | 2.752 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.744612e-03 | 2.758 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.699089e-03 | 2.770 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.814477e-03 | 2.741 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.105441e-03 | 2.677 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.433554e-03 | 2.614 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 2.433554e-03 | 2.614 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.650115e-03 | 2.577 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.650115e-03 | 2.577 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.650115e-03 | 2.577 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.790979e-03 | 2.554 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 3.167189e-03 | 2.499 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.207510e-03 | 2.494 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 3.207510e-03 | 2.494 | 0 | 0 |
| IRS activation | R-HSA-74713 | 3.442501e-03 | 2.463 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.699795e-03 | 2.432 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.699795e-03 | 2.432 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.679337e-03 | 2.434 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 4.038713e-03 | 2.394 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 4.046150e-03 | 2.393 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.835157e-03 | 2.416 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 4.101839e-03 | 2.387 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 4.417340e-03 | 2.355 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.499059e-03 | 2.347 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 4.814540e-03 | 2.317 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 4.690756e-03 | 2.329 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 4.981644e-03 | 2.303 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 4.981644e-03 | 2.303 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 5.059365e-03 | 2.296 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 5.346156e-03 | 2.272 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 5.339612e-03 | 2.272 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 5.059365e-03 | 2.296 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 5.073184e-03 | 2.295 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 5.383561e-03 | 2.269 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 5.477235e-03 | 2.261 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 5.477235e-03 | 2.261 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 6.240849e-03 | 2.205 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 6.240849e-03 | 2.205 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 6.240849e-03 | 2.205 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 6.830817e-03 | 2.166 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 6.830817e-03 | 2.166 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 6.419196e-03 | 2.193 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 6.830817e-03 | 2.166 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 6.538278e-03 | 2.185 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 7.140948e-03 | 2.146 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 7.283250e-03 | 2.138 | 0 | 0 |
| Transport of glycerol from adipocytes to the liver by Aquaporins | R-HSA-432030 | 7.368814e-03 | 2.133 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 7.590127e-03 | 2.120 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 7.632485e-03 | 2.117 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 8.033095e-03 | 2.095 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 8.095129e-03 | 2.092 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 9.119657e-03 | 2.040 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 9.119657e-03 | 2.040 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 8.838333e-03 | 2.054 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 9.119657e-03 | 2.040 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 9.146139e-03 | 2.039 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 9.547439e-03 | 2.020 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.547439e-03 | 2.020 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.547439e-03 | 2.020 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 1.062408e-02 | 1.974 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.083707e-02 | 1.965 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 9.978089e-03 | 2.001 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.020639e-02 | 1.991 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.068170e-02 | 1.971 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.087452e-02 | 1.964 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.087452e-02 | 1.964 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.098416e-02 | 1.959 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 1.274189e-02 | 1.895 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 1.274189e-02 | 1.895 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.274189e-02 | 1.895 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 1.274189e-02 | 1.895 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.180398e-02 | 1.928 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.180398e-02 | 1.928 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.180398e-02 | 1.928 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 1.232226e-02 | 1.909 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.275028e-02 | 1.894 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.275028e-02 | 1.894 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.389528e-02 | 1.857 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.389528e-02 | 1.857 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 1.389528e-02 | 1.857 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.389528e-02 | 1.857 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.389528e-02 | 1.857 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.586345e-02 | 1.800 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.486644e-02 | 1.828 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.486644e-02 | 1.828 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.486064e-02 | 1.828 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.569541e-02 | 1.804 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.443244e-02 | 1.841 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.443244e-02 | 1.841 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.644974e-02 | 1.784 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.672036e-02 | 1.777 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.719191e-02 | 1.765 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 1.719191e-02 | 1.765 | 0 | 0 |
| PKA activation | R-HSA-163615 | 1.719191e-02 | 1.765 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.719191e-02 | 1.765 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.738965e-02 | 1.760 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.743442e-02 | 1.759 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 1.743442e-02 | 1.759 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 1.936672e-02 | 1.713 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 1.832304e-02 | 1.737 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.832304e-02 | 1.737 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.940851e-02 | 1.712 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 1.940851e-02 | 1.712 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 1.973231e-02 | 1.705 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.901377e-02 | 1.721 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.973231e-02 | 1.705 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.824111e-02 | 1.739 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.005534e-02 | 1.698 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.012830e-02 | 1.696 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.042603e-02 | 1.690 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 2.042603e-02 | 1.690 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 2.204385e-02 | 1.657 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 2.219505e-02 | 1.654 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 2.246361e-02 | 1.649 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 2.256606e-02 | 1.647 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 2.256606e-02 | 1.647 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 2.256606e-02 | 1.647 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.713089e-02 | 1.567 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.713089e-02 | 1.567 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.713089e-02 | 1.567 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 2.713089e-02 | 1.567 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 2.713089e-02 | 1.567 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 2.713089e-02 | 1.567 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.547635e-02 | 1.594 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.547635e-02 | 1.594 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.688094e-02 | 1.571 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.378368e-02 | 1.624 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.619106e-02 | 1.582 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 2.547635e-02 | 1.594 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.653966e-02 | 1.576 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 2.547635e-02 | 1.594 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.564086e-02 | 1.591 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.404259e-02 | 1.619 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.715020e-02 | 1.566 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 2.784038e-02 | 1.555 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 2.833105e-02 | 1.548 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.868732e-02 | 1.542 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.868732e-02 | 1.542 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.868732e-02 | 1.542 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 2.868991e-02 | 1.542 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.874869e-02 | 1.541 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.095174e-02 | 1.509 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 3.116984e-02 | 1.506 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 3.116984e-02 | 1.506 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 3.145900e-02 | 1.502 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 3.191640e-02 | 1.496 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 3.432407e-02 | 1.464 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 3.432407e-02 | 1.464 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.432407e-02 | 1.464 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | R-HSA-9646304 | 4.135022e-02 | 1.384 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p14ARF Defects | R-HSA-9646303 | 4.135022e-02 | 1.384 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 3.592914e-02 | 1.445 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.579984e-02 | 1.446 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 3.970431e-02 | 1.401 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 4.052546e-02 | 1.392 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 4.022068e-02 | 1.396 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 3.557051e-02 | 1.449 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 3.524038e-02 | 1.453 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 3.626767e-02 | 1.440 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 3.626767e-02 | 1.440 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 4.057207e-02 | 1.392 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 3.844726e-02 | 1.415 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 4.086872e-02 | 1.389 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.655810e-02 | 1.437 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.655810e-02 | 1.437 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.970431e-02 | 1.401 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.970431e-02 | 1.401 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 3.592914e-02 | 1.445 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.592914e-02 | 1.445 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.579984e-02 | 1.446 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 4.176576e-02 | 1.379 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 4.176576e-02 | 1.379 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.296934e-02 | 1.367 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 4.384170e-02 | 1.358 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 4.384170e-02 | 1.358 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.384170e-02 | 1.358 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 4.463861e-02 | 1.350 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 4.478497e-02 | 1.349 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 4.478497e-02 | 1.349 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 4.566292e-02 | 1.340 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 4.566292e-02 | 1.340 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 4.566292e-02 | 1.340 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 4.566292e-02 | 1.340 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 4.641740e-02 | 1.333 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 4.641740e-02 | 1.333 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 4.765688e-02 | 1.322 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 4.765688e-02 | 1.322 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.821178e-02 | 1.317 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.886189e-02 | 1.311 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 4.916264e-02 | 1.308 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 5.012407e-02 | 1.300 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 5.624008e-02 | 1.250 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 5.624008e-02 | 1.250 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 5.393227e-02 | 1.268 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 6.058188e-02 | 1.218 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 6.270657e-02 | 1.203 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 6.270657e-02 | 1.203 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 5.699398e-02 | 1.244 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.393227e-02 | 1.268 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.393227e-02 | 1.268 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 5.764597e-02 | 1.239 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 5.484456e-02 | 1.261 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.297661e-02 | 1.276 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.393227e-02 | 1.268 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 5.885835e-02 | 1.230 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 5.764597e-02 | 1.239 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 5.876911e-02 | 1.231 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 6.199127e-02 | 1.208 | 1 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 5.624008e-02 | 1.250 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 5.281369e-02 | 1.277 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 5.764597e-02 | 1.239 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 6.117884e-02 | 1.213 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 6.296949e-02 | 1.201 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 5.882662e-02 | 1.230 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 5.624008e-02 | 1.250 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 5.097720e-02 | 1.293 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.285981e-02 | 1.277 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 5.281369e-02 | 1.277 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 5.484456e-02 | 1.261 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 6.359505e-02 | 1.197 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 6.378037e-02 | 1.195 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 6.727261e-02 | 1.172 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.757443e-02 | 1.170 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 6.757443e-02 | 1.170 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 6.794326e-02 | 1.168 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.799294e-02 | 1.168 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 6.799294e-02 | 1.168 | 0 | 0 |
| Kinesins | R-HSA-983189 | 7.110753e-02 | 1.148 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 7.173517e-02 | 1.144 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 7.173517e-02 | 1.144 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.183626e-02 | 1.144 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 7.350201e-02 | 1.134 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 7.495808e-02 | 1.125 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 7.495808e-02 | 1.125 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 7.495808e-02 | 1.125 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 7.495808e-02 | 1.125 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.504713e-02 | 1.125 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 7.504713e-02 | 1.125 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 7.595768e-02 | 1.119 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 7.635607e-02 | 1.117 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 7.710860e-02 | 1.113 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 7.710860e-02 | 1.113 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 7.710860e-02 | 1.113 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 8.099302e-02 | 1.092 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 8.099302e-02 | 1.092 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 8.099302e-02 | 1.092 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 8.099302e-02 | 1.092 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 7.958547e-02 | 1.099 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 7.958547e-02 | 1.099 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 9.219805e-02 | 1.035 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 9.219805e-02 | 1.035 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.053420e-01 | 0.977 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 9.068523e-02 | 1.042 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 9.902098e-02 | 1.004 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.902098e-02 | 1.004 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 9.115439e-02 | 1.040 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 9.219805e-02 | 1.035 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.742219e-02 | 1.058 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.958547e-02 | 1.099 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.768769e-02 | 1.010 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 9.219805e-02 | 1.035 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.053420e-01 | 0.977 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.053420e-01 | 0.977 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.797786e-02 | 1.009 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.132765e-02 | 1.039 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 8.742219e-02 | 1.058 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 9.219805e-02 | 1.035 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 9.768769e-02 | 1.010 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.170639e-02 | 1.038 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 8.099302e-02 | 1.092 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 9.219805e-02 | 1.035 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 1.053420e-01 | 0.977 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.132765e-02 | 1.039 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 8.699099e-02 | 1.061 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 9.811832e-02 | 1.008 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 8.977295e-02 | 1.047 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 1.053420e-01 | 0.977 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.053420e-01 | 0.977 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.017809e-01 | 0.992 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 9.768769e-02 | 1.010 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 7.958547e-02 | 1.099 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 7.983457e-02 | 1.098 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 8.454331e-02 | 1.073 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.035720e-01 | 0.985 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 9.219805e-02 | 1.035 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.053420e-01 | 0.977 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 9.115439e-02 | 1.040 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.279893e-02 | 1.032 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 8.568183e-02 | 1.067 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 8.517356e-02 | 1.070 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 9.902098e-02 | 1.004 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.053420e-01 | 0.977 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.059547e-01 | 0.975 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.073158e-01 | 0.969 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.073158e-01 | 0.969 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 1.076521e-01 | 0.968 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 1.076521e-01 | 0.968 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 1.076521e-01 | 0.968 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 1.076521e-01 | 0.968 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 1.189988e-01 | 0.924 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 1.189988e-01 | 0.924 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 1.189988e-01 | 0.924 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 1.189988e-01 | 0.924 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 1.189988e-01 | 0.924 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 1.189988e-01 | 0.924 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 1.189988e-01 | 0.924 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 1.189988e-01 | 0.924 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 1.189988e-01 | 0.924 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.554350e-01 | 0.808 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.554350e-01 | 0.808 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.554350e-01 | 0.808 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.554350e-01 | 0.808 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.554350e-01 | 0.808 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.554350e-01 | 0.808 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.554350e-01 | 0.808 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.554350e-01 | 0.808 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 1.554350e-01 | 0.808 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.554350e-01 | 0.808 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.554350e-01 | 0.808 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.554350e-01 | 0.808 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 1.329673e-01 | 0.876 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.329673e-01 | 0.876 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 1.619907e-01 | 0.791 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 1.165637e-01 | 0.933 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.165637e-01 | 0.933 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.165637e-01 | 0.933 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 1.257404e-01 | 0.901 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 1.448278e-01 | 0.839 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.110048e-01 | 0.955 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.188153e-01 | 0.925 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.315493e-01 | 0.881 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.154200e-01 | 0.938 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.415223e-01 | 0.849 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.367444e-01 | 0.864 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.475064e-01 | 0.831 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.157426e-01 | 0.937 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.370942e-01 | 0.863 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.329673e-01 | 0.876 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 1.179506e-01 | 0.928 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.444340e-01 | 0.840 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 1.473311e-01 | 0.832 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 1.444340e-01 | 0.840 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.209946e-01 | 0.917 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 1.619907e-01 | 0.791 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 1.619907e-01 | 0.791 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.553058e-01 | 0.809 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.315493e-01 | 0.881 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.170936e-01 | 0.931 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.262180e-01 | 0.899 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.547074e-01 | 0.810 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.189521e-01 | 0.925 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.179506e-01 | 0.928 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 1.597503e-01 | 0.797 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.370942e-01 | 0.863 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.473311e-01 | 0.832 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 1.308197e-01 | 0.883 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 1.547074e-01 | 0.810 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.599394e-01 | 0.796 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.553058e-01 | 0.809 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 1.189988e-01 | 0.924 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 1.189988e-01 | 0.924 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.189521e-01 | 0.925 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.329673e-01 | 0.876 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.473311e-01 | 0.832 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.129948e-01 | 0.947 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.597503e-01 | 0.797 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.397269e-01 | 0.855 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.481697e-01 | 0.829 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.597503e-01 | 0.797 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 1.475064e-01 | 0.831 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.148935e-01 | 0.940 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 1.264934e-01 | 0.898 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.148935e-01 | 0.940 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 1.434485e-01 | 0.843 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.180379e-01 | 0.928 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 1.264934e-01 | 0.898 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.203007e-01 | 0.920 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.398645e-01 | 0.854 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.158809e-01 | 0.936 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.262180e-01 | 0.899 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.473311e-01 | 0.832 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.233394e-01 | 0.909 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 1.398645e-01 | 0.854 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 1.398645e-01 | 0.854 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.189988e-01 | 0.924 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.158809e-01 | 0.936 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.475064e-01 | 0.831 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.619907e-01 | 0.791 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 1.553058e-01 | 0.809 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.481697e-01 | 0.829 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.238504e-01 | 0.907 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.370942e-01 | 0.863 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 1.547074e-01 | 0.810 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.255048e-01 | 0.901 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.554350e-01 | 0.808 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.473311e-01 | 0.832 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.274660e-01 | 0.895 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.292155e-01 | 0.889 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.379985e-01 | 0.860 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 1.257404e-01 | 0.901 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.369864e-01 | 0.863 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.105514e-01 | 0.956 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 1.110048e-01 | 0.955 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.370942e-01 | 0.863 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.619907e-01 | 0.791 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.473311e-01 | 0.832 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 1.444340e-01 | 0.840 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.352379e-01 | 0.869 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.632455e-01 | 0.787 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.632455e-01 | 0.787 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.632455e-01 | 0.787 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.632455e-01 | 0.787 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.632455e-01 | 0.787 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.632455e-01 | 0.787 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 1.632558e-01 | 0.787 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.636733e-01 | 0.786 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 1.647906e-01 | 0.783 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.655911e-01 | 0.781 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.712947e-01 | 0.766 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.717088e-01 | 0.765 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 1.750618e-01 | 0.757 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 1.768973e-01 | 0.752 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.768973e-01 | 0.752 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.768973e-01 | 0.752 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 1.795792e-01 | 0.746 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 1.817211e-01 | 0.741 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 1.830468e-01 | 0.737 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.840250e-01 | 0.735 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.840250e-01 | 0.735 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 1.855060e-01 | 0.732 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.855060e-01 | 0.732 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 1.855060e-01 | 0.732 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.855060e-01 | 0.732 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 1.855060e-01 | 0.732 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.873525e-01 | 0.727 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.873525e-01 | 0.727 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 1.879383e-01 | 0.726 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 1.879383e-01 | 0.726 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.903665e-01 | 0.720 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 1.903665e-01 | 0.720 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 1.903665e-01 | 0.720 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 2.238552e-01 | 0.650 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 2.238552e-01 | 0.650 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 2.238552e-01 | 0.650 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 2.238552e-01 | 0.650 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.238552e-01 | 0.650 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 2.238552e-01 | 0.650 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.238552e-01 | 0.650 | 0 | 0 |
| Activation of AMPA receptors | R-HSA-399710 | 2.559607e-01 | 0.592 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.559607e-01 | 0.592 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 2.559607e-01 | 0.592 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.559607e-01 | 0.592 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 2.559607e-01 | 0.592 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 2.867399e-01 | 0.543 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 2.867399e-01 | 0.543 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 2.867399e-01 | 0.543 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 2.867399e-01 | 0.543 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 2.867399e-01 | 0.543 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.162478e-01 | 0.500 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 3.162478e-01 | 0.500 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.162478e-01 | 0.500 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.920054e-01 | 0.717 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.072730e-01 | 0.683 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.445365e-01 | 0.463 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 3.445365e-01 | 0.463 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 3.445365e-01 | 0.463 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 3.445365e-01 | 0.463 | 0 | 0 |
| FGFR3b ligand binding and activation | R-HSA-190371 | 3.445365e-01 | 0.463 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.445365e-01 | 0.463 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.381337e-01 | 0.623 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 3.716566e-01 | 0.430 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 3.716566e-01 | 0.430 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.716566e-01 | 0.430 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 3.716566e-01 | 0.430 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 2.847390e-01 | 0.546 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.287171e-01 | 0.641 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.398071e-01 | 0.620 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.622365e-01 | 0.581 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.310557e-01 | 0.480 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.494613e-01 | 0.603 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 3.614752e-01 | 0.442 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.077406e-01 | 0.512 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 3.191825e-01 | 0.496 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.770452e-01 | 0.557 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 3.145017e-01 | 0.502 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 3.157356e-01 | 0.501 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 3.002424e-01 | 0.523 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 2.226611e-01 | 0.652 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.920054e-01 | 0.717 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.050152e-01 | 0.688 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.225219e-01 | 0.653 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.711743e-01 | 0.430 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 3.145050e-01 | 0.502 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 2.226611e-01 | 0.652 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.191825e-01 | 0.496 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.999422e-01 | 0.523 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.225543e-01 | 0.653 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.225543e-01 | 0.653 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 2.770452e-01 | 0.557 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.436992e-01 | 0.613 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 3.523075e-01 | 0.453 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.806384e-01 | 0.552 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 2.559607e-01 | 0.592 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 3.445365e-01 | 0.463 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 3.534947e-01 | 0.452 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.981296e-01 | 0.703 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 3.157356e-01 | 0.501 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.455295e-01 | 0.462 | 1 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.226611e-01 | 0.652 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 2.735501e-01 | 0.563 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 2.559607e-01 | 0.592 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 1.920054e-01 | 0.717 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 2.999422e-01 | 0.523 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 2.536576e-01 | 0.596 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 2.398071e-01 | 0.620 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.849132e-01 | 0.545 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.263333e-01 | 0.645 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.957000e-01 | 0.529 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.536576e-01 | 0.596 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 3.505830e-01 | 0.455 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.587403e-01 | 0.445 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.559607e-01 | 0.592 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 2.559607e-01 | 0.592 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 2.867399e-01 | 0.543 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.867399e-01 | 0.543 | 0 | 0 |
| Intracellular metabolism of fatty acids regulates insulin secretion | R-HSA-434313 | 3.162478e-01 | 0.500 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 3.716566e-01 | 0.430 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 2.068537e-01 | 0.684 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.614752e-01 | 0.442 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.239478e-01 | 0.490 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.966293e-01 | 0.528 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 2.381337e-01 | 0.623 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.901731e-01 | 0.721 | 1 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.847390e-01 | 0.546 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.263333e-01 | 0.645 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.559607e-01 | 0.592 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 3.716566e-01 | 0.430 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.191825e-01 | 0.496 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.191825e-01 | 0.496 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 3.428830e-01 | 0.465 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 3.569054e-01 | 0.447 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.534947e-01 | 0.452 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 2.029358e-01 | 0.693 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.445365e-01 | 0.463 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.445365e-01 | 0.463 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.716566e-01 | 0.430 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.966775e-01 | 0.706 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 2.359669e-01 | 0.627 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.605259e-01 | 0.584 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.287171e-01 | 0.641 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.225219e-01 | 0.653 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 3.077406e-01 | 0.512 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.152434e-01 | 0.667 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 2.072730e-01 | 0.683 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.585937e-01 | 0.587 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 3.523634e-01 | 0.453 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.514976e-01 | 0.599 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 2.598517e-01 | 0.585 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 2.944737e-01 | 0.531 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 2.944737e-01 | 0.531 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 2.598517e-01 | 0.585 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 2.286376e-01 | 0.641 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.523075e-01 | 0.453 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 3.762619e-01 | 0.425 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 3.762619e-01 | 0.425 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.463239e-01 | 0.461 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 1.903665e-01 | 0.720 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 1.903665e-01 | 0.720 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 2.238552e-01 | 0.650 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.559607e-01 | 0.592 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 2.867399e-01 | 0.543 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 2.072730e-01 | 0.683 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 3.445365e-01 | 0.463 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 3.445365e-01 | 0.463 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 3.445365e-01 | 0.463 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 3.716566e-01 | 0.430 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 3.716566e-01 | 0.430 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 3.716566e-01 | 0.430 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 3.716566e-01 | 0.430 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 2.068537e-01 | 0.684 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 2.287171e-01 | 0.641 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 2.398071e-01 | 0.620 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 3.614752e-01 | 0.442 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.585937e-01 | 0.587 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 3.077406e-01 | 0.512 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.191825e-01 | 0.496 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.930546e-01 | 0.714 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 2.068537e-01 | 0.684 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.867399e-01 | 0.543 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 1.903665e-01 | 0.720 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.162478e-01 | 0.500 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 2.226611e-01 | 0.652 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.287171e-01 | 0.641 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 2.963139e-01 | 0.528 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.226611e-01 | 0.652 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.077406e-01 | 0.512 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 1.903665e-01 | 0.720 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.238552e-01 | 0.650 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.559607e-01 | 0.592 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 2.559607e-01 | 0.592 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.559607e-01 | 0.592 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 2.867399e-01 | 0.543 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.445365e-01 | 0.463 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 3.445365e-01 | 0.463 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 3.445365e-01 | 0.463 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 3.716566e-01 | 0.430 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 3.716566e-01 | 0.430 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 2.692021e-01 | 0.570 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.463239e-01 | 0.461 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 3.463239e-01 | 0.461 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 3.334092e-01 | 0.477 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.947678e-01 | 0.710 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.433420e-01 | 0.614 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.145017e-01 | 0.502 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.145017e-01 | 0.502 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.145017e-01 | 0.502 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 3.402740e-01 | 0.468 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 2.509846e-01 | 0.600 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.735501e-01 | 0.563 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 2.785371e-01 | 0.555 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.536576e-01 | 0.596 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.930546e-01 | 0.714 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.559607e-01 | 0.592 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 2.867399e-01 | 0.543 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 2.867399e-01 | 0.543 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 3.162478e-01 | 0.500 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 3.162478e-01 | 0.500 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 2.226611e-01 | 0.652 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.716566e-01 | 0.430 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.847390e-01 | 0.546 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 3.310557e-01 | 0.480 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 3.420695e-01 | 0.466 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 3.420695e-01 | 0.466 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.387101e-01 | 0.470 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 2.029358e-01 | 0.693 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.920054e-01 | 0.717 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.536576e-01 | 0.596 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.847390e-01 | 0.546 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 3.002424e-01 | 0.523 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 2.677478e-01 | 0.572 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.975992e-01 | 0.704 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.912082e-01 | 0.718 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 3.145050e-01 | 0.502 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 3.310557e-01 | 0.480 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 2.559607e-01 | 0.592 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 2.867399e-01 | 0.543 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.920054e-01 | 0.717 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.920054e-01 | 0.717 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.672750e-01 | 0.573 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.068537e-01 | 0.684 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 3.145050e-01 | 0.502 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.186786e-01 | 0.497 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 3.239318e-01 | 0.490 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 2.735501e-01 | 0.563 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.439243e-01 | 0.464 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.002424e-01 | 0.523 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 2.494613e-01 | 0.603 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 3.310557e-01 | 0.480 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 2.509846e-01 | 0.600 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 3.716566e-01 | 0.430 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.156885e-01 | 0.501 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 3.614752e-01 | 0.442 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 3.310557e-01 | 0.480 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 3.428830e-01 | 0.465 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 3.764932e-01 | 0.424 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 3.764932e-01 | 0.424 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 3.764932e-01 | 0.424 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.807875e-01 | 0.419 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 3.902384e-01 | 0.409 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 3.913628e-01 | 0.407 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 3.913628e-01 | 0.407 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 3.913628e-01 | 0.407 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 3.913628e-01 | 0.407 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 3.931151e-01 | 0.405 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 3.959038e-01 | 0.402 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 3.964392e-01 | 0.402 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.976561e-01 | 0.400 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 3.976561e-01 | 0.400 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 3.976561e-01 | 0.400 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 3.976561e-01 | 0.400 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.976561e-01 | 0.400 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.976561e-01 | 0.400 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 3.976561e-01 | 0.400 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 3.976561e-01 | 0.400 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.976561e-01 | 0.400 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.976561e-01 | 0.400 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 3.976561e-01 | 0.400 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 3.976561e-01 | 0.400 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 3.976561e-01 | 0.400 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 3.976561e-01 | 0.400 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.976561e-01 | 0.400 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 3.976561e-01 | 0.400 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.976561e-01 | 0.400 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.988609e-01 | 0.399 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 4.006739e-01 | 0.397 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 4.033359e-01 | 0.394 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 4.060708e-01 | 0.391 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 4.060708e-01 | 0.391 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 4.100775e-01 | 0.387 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 4.100775e-01 | 0.387 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 4.147408e-01 | 0.382 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 4.184484e-01 | 0.378 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 4.206051e-01 | 0.376 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 4.206051e-01 | 0.376 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 4.206051e-01 | 0.376 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.225814e-01 | 0.374 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.225814e-01 | 0.374 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.225814e-01 | 0.374 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.225814e-01 | 0.374 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 4.225814e-01 | 0.374 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 4.225814e-01 | 0.374 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 4.225814e-01 | 0.374 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 4.225814e-01 | 0.374 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 4.225814e-01 | 0.374 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 4.225814e-01 | 0.374 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 4.229586e-01 | 0.374 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 4.277882e-01 | 0.369 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 4.277882e-01 | 0.369 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.323086e-01 | 0.364 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 4.323086e-01 | 0.364 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 4.329763e-01 | 0.364 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 4.349549e-01 | 0.362 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 4.349549e-01 | 0.362 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 4.349549e-01 | 0.362 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 4.370888e-01 | 0.359 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 4.370888e-01 | 0.359 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 4.393278e-01 | 0.357 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 4.393278e-01 | 0.357 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.403467e-01 | 0.356 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 4.406554e-01 | 0.356 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 4.433097e-01 | 0.353 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.433097e-01 | 0.353 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 4.463460e-01 | 0.350 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 4.464766e-01 | 0.350 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 4.464766e-01 | 0.350 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 4.464766e-01 | 0.350 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 4.464766e-01 | 0.350 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 4.464766e-01 | 0.350 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 4.464766e-01 | 0.350 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 4.464766e-01 | 0.350 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 4.464766e-01 | 0.350 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 4.464766e-01 | 0.350 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 4.464766e-01 | 0.350 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.464766e-01 | 0.350 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 4.464766e-01 | 0.350 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 4.464766e-01 | 0.350 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.464766e-01 | 0.350 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 4.474729e-01 | 0.349 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 4.477094e-01 | 0.349 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 4.491106e-01 | 0.348 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 4.491106e-01 | 0.348 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 4.491106e-01 | 0.348 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 4.491106e-01 | 0.348 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 4.550461e-01 | 0.342 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 4.555555e-01 | 0.341 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.555555e-01 | 0.341 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 4.594960e-01 | 0.338 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 4.604294e-01 | 0.337 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 4.630636e-01 | 0.334 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 4.630636e-01 | 0.334 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 4.630636e-01 | 0.334 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 4.636692e-01 | 0.334 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 4.647135e-01 | 0.333 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.650529e-01 | 0.332 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 4.693845e-01 | 0.328 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 4.693845e-01 | 0.328 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.693845e-01 | 0.328 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 4.693845e-01 | 0.328 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 4.693845e-01 | 0.328 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 4.693845e-01 | 0.328 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.693845e-01 | 0.328 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.693845e-01 | 0.328 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.693845e-01 | 0.328 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 4.693845e-01 | 0.328 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.757838e-01 | 0.323 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.757838e-01 | 0.323 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.757838e-01 | 0.323 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 4.768066e-01 | 0.322 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 4.768066e-01 | 0.322 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 4.768066e-01 | 0.322 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 4.814874e-01 | 0.317 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 4.903330e-01 | 0.310 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 4.903330e-01 | 0.310 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 4.903330e-01 | 0.310 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 4.903330e-01 | 0.310 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 4.903330e-01 | 0.310 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 4.903330e-01 | 0.310 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 4.913456e-01 | 0.309 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.913456e-01 | 0.309 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 4.913456e-01 | 0.309 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.913456e-01 | 0.309 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 4.913456e-01 | 0.309 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 4.913456e-01 | 0.309 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.913456e-01 | 0.309 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 4.913456e-01 | 0.309 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.913456e-01 | 0.309 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.913456e-01 | 0.309 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 4.913456e-01 | 0.309 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 4.913456e-01 | 0.309 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 4.913456e-01 | 0.309 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 4.913456e-01 | 0.309 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 4.913456e-01 | 0.309 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 4.913456e-01 | 0.309 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 4.969395e-01 | 0.304 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.969395e-01 | 0.304 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 5.036373e-01 | 0.298 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 5.036373e-01 | 0.298 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.073552e-01 | 0.295 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 5.073552e-01 | 0.295 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 5.096057e-01 | 0.293 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 5.104450e-01 | 0.292 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 5.113130e-01 | 0.291 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 5.123990e-01 | 0.290 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 5.123990e-01 | 0.290 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 5.123990e-01 | 0.290 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 5.123990e-01 | 0.290 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 5.123990e-01 | 0.290 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 5.123990e-01 | 0.290 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.123990e-01 | 0.290 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 5.123990e-01 | 0.290 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 5.123990e-01 | 0.290 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.123990e-01 | 0.290 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 5.123990e-01 | 0.290 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.123990e-01 | 0.290 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 5.123990e-01 | 0.290 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 5.123990e-01 | 0.290 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 5.167146e-01 | 0.287 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 5.167146e-01 | 0.287 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 5.167146e-01 | 0.287 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 5.167146e-01 | 0.287 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 5.167146e-01 | 0.287 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 5.176574e-01 | 0.286 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 5.176574e-01 | 0.286 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 5.325823e-01 | 0.274 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 5.325823e-01 | 0.274 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 5.325823e-01 | 0.274 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 5.325823e-01 | 0.274 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 5.325823e-01 | 0.274 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 5.325823e-01 | 0.274 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 5.325823e-01 | 0.274 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 5.325823e-01 | 0.274 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 5.325823e-01 | 0.274 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 5.325823e-01 | 0.274 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 5.325823e-01 | 0.274 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 5.325823e-01 | 0.274 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 5.325823e-01 | 0.274 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 5.339981e-01 | 0.272 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 5.344828e-01 | 0.272 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 5.379068e-01 | 0.269 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 5.379068e-01 | 0.269 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 5.379068e-01 | 0.269 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 5.385906e-01 | 0.269 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 5.386858e-01 | 0.269 | 1 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 5.393400e-01 | 0.268 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 5.421731e-01 | 0.266 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 5.421731e-01 | 0.266 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 5.440151e-01 | 0.264 | 1 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 5.442535e-01 | 0.264 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 5.476105e-01 | 0.262 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 5.519313e-01 | 0.258 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 5.519313e-01 | 0.258 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 5.519313e-01 | 0.258 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 5.519313e-01 | 0.258 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 5.519313e-01 | 0.258 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 5.519313e-01 | 0.258 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 5.519313e-01 | 0.258 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.519313e-01 | 0.258 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 5.519313e-01 | 0.258 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 5.519313e-01 | 0.258 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 5.519313e-01 | 0.258 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.519313e-01 | 0.258 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 5.519313e-01 | 0.258 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 5.519313e-01 | 0.258 | 0 | 0 |
| S Phase | R-HSA-69242 | 5.525382e-01 | 0.258 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 5.544512e-01 | 0.256 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 5.545484e-01 | 0.256 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 5.545484e-01 | 0.256 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 5.576617e-01 | 0.254 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.576617e-01 | 0.254 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 5.653383e-01 | 0.248 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 5.666848e-01 | 0.247 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 5.666848e-01 | 0.247 | 0 | 0 |
| Depurination | R-HSA-73927 | 5.666848e-01 | 0.247 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 5.666848e-01 | 0.247 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 5.673469e-01 | 0.246 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 5.673469e-01 | 0.246 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.673469e-01 | 0.246 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 5.673469e-01 | 0.246 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.673469e-01 | 0.246 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 5.693906e-01 | 0.245 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 5.704805e-01 | 0.244 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 5.704805e-01 | 0.244 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 5.704805e-01 | 0.244 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.704805e-01 | 0.244 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 5.704805e-01 | 0.244 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 5.704805e-01 | 0.244 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.704805e-01 | 0.244 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 5.704805e-01 | 0.244 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 5.704805e-01 | 0.244 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 5.704805e-01 | 0.244 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 5.704805e-01 | 0.244 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 5.704805e-01 | 0.244 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.704805e-01 | 0.244 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.704805e-01 | 0.244 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 5.704805e-01 | 0.244 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 5.704805e-01 | 0.244 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 5.704805e-01 | 0.244 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 5.719399e-01 | 0.243 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 5.769008e-01 | 0.239 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 5.769008e-01 | 0.239 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 5.785810e-01 | 0.238 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 5.785810e-01 | 0.238 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 5.785810e-01 | 0.238 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 5.792418e-01 | 0.237 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 5.836137e-01 | 0.234 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 5.836137e-01 | 0.234 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 5.857128e-01 | 0.232 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 5.857128e-01 | 0.232 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.882628e-01 | 0.230 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 5.882628e-01 | 0.230 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.882628e-01 | 0.230 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 5.882628e-01 | 0.230 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 5.882628e-01 | 0.230 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 5.882628e-01 | 0.230 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 5.882628e-01 | 0.230 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 5.884448e-01 | 0.230 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 5.902359e-01 | 0.229 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 5.902359e-01 | 0.229 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 5.902359e-01 | 0.229 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 5.902359e-01 | 0.229 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 5.902359e-01 | 0.229 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 5.957451e-01 | 0.225 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 5.973369e-01 | 0.224 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 6.007422e-01 | 0.221 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 6.009859e-01 | 0.221 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 6.016493e-01 | 0.221 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 6.016493e-01 | 0.221 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 6.016493e-01 | 0.221 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 6.016493e-01 | 0.221 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 6.016701e-01 | 0.221 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 6.016701e-01 | 0.221 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 6.053100e-01 | 0.218 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 6.053100e-01 | 0.218 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.053100e-01 | 0.218 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 6.053100e-01 | 0.218 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.053100e-01 | 0.218 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.053100e-01 | 0.218 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 6.053100e-01 | 0.218 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 6.076943e-01 | 0.216 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.095083e-01 | 0.215 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 6.128211e-01 | 0.213 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 6.172511e-01 | 0.210 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 6.216524e-01 | 0.206 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.216524e-01 | 0.206 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 6.216524e-01 | 0.206 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.216524e-01 | 0.206 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 6.216524e-01 | 0.206 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.216524e-01 | 0.206 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 6.216524e-01 | 0.206 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 6.216524e-01 | 0.206 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.216524e-01 | 0.206 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 6.226371e-01 | 0.206 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.230423e-01 | 0.205 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 6.237517e-01 | 0.205 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 6.237517e-01 | 0.205 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 6.237517e-01 | 0.205 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 6.237517e-01 | 0.205 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 6.237517e-01 | 0.205 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 6.248974e-01 | 0.204 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 6.313682e-01 | 0.200 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 6.324647e-01 | 0.199 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 6.344419e-01 | 0.198 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 6.351527e-01 | 0.197 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 6.351527e-01 | 0.197 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 6.373190e-01 | 0.196 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.373190e-01 | 0.196 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.373190e-01 | 0.196 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.373190e-01 | 0.196 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.373190e-01 | 0.196 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 6.373190e-01 | 0.196 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.373190e-01 | 0.196 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 6.373190e-01 | 0.196 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 6.373190e-01 | 0.196 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.373190e-01 | 0.196 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 6.385948e-01 | 0.195 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 6.390691e-01 | 0.194 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 6.399585e-01 | 0.194 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 6.446638e-01 | 0.191 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 6.448930e-01 | 0.191 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 6.448930e-01 | 0.191 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 6.448930e-01 | 0.191 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.472478e-01 | 0.189 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 6.484073e-01 | 0.188 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 6.493975e-01 | 0.187 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 6.506711e-01 | 0.187 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 6.506711e-01 | 0.187 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 6.506711e-01 | 0.187 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 6.523379e-01 | 0.186 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.523379e-01 | 0.186 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 6.523379e-01 | 0.186 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.523379e-01 | 0.186 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 6.523379e-01 | 0.186 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 6.523379e-01 | 0.186 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 6.523379e-01 | 0.186 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 6.523379e-01 | 0.186 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 6.544991e-01 | 0.184 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.544991e-01 | 0.184 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 6.551064e-01 | 0.184 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 6.551064e-01 | 0.184 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 6.613321e-01 | 0.180 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 6.648792e-01 | 0.177 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 6.650839e-01 | 0.177 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 6.650839e-01 | 0.177 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 6.650839e-01 | 0.177 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 6.667357e-01 | 0.176 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 6.667357e-01 | 0.176 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.667357e-01 | 0.176 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.667357e-01 | 0.176 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 6.667357e-01 | 0.176 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 6.667357e-01 | 0.176 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 6.683172e-01 | 0.175 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 6.686997e-01 | 0.175 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 6.739567e-01 | 0.171 | 1 | 1 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 6.805381e-01 | 0.167 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.805381e-01 | 0.167 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 6.805381e-01 | 0.167 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 6.805381e-01 | 0.167 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 6.805381e-01 | 0.167 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 6.805381e-01 | 0.167 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 6.805381e-01 | 0.167 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 6.807826e-01 | 0.167 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 6.807826e-01 | 0.167 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 6.807826e-01 | 0.167 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 6.843392e-01 | 0.165 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 6.843392e-01 | 0.165 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 6.857504e-01 | 0.164 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 6.868884e-01 | 0.163 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 6.885353e-01 | 0.162 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 6.899269e-01 | 0.161 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 6.909280e-01 | 0.161 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 6.923019e-01 | 0.160 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 6.927974e-01 | 0.159 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 6.936218e-01 | 0.159 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 6.937696e-01 | 0.159 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 6.937696e-01 | 0.159 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 6.937696e-01 | 0.159 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 6.937696e-01 | 0.159 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 6.937696e-01 | 0.159 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 6.937696e-01 | 0.159 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 6.937696e-01 | 0.159 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 6.937696e-01 | 0.159 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 6.937696e-01 | 0.159 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 6.937696e-01 | 0.159 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 6.958826e-01 | 0.157 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 7.011175e-01 | 0.154 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 7.011175e-01 | 0.154 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 7.024233e-01 | 0.153 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 7.035752e-01 | 0.153 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 7.064539e-01 | 0.151 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 7.064539e-01 | 0.151 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 7.088619e-01 | 0.149 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 7.110843e-01 | 0.148 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 7.115102e-01 | 0.148 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 7.115102e-01 | 0.148 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 7.125415e-01 | 0.147 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 7.128027e-01 | 0.147 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 7.153200e-01 | 0.145 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.186135e-01 | 0.144 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.186135e-01 | 0.144 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 7.186135e-01 | 0.144 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 7.198886e-01 | 0.143 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 7.198886e-01 | 0.143 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 7.201219e-01 | 0.143 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 7.201219e-01 | 0.143 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 7.201219e-01 | 0.143 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 7.214335e-01 | 0.142 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 7.251047e-01 | 0.140 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 7.270328e-01 | 0.138 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 7.302702e-01 | 0.137 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 7.302702e-01 | 0.137 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 7.302702e-01 | 0.137 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 7.302702e-01 | 0.137 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 7.302702e-01 | 0.137 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 7.302702e-01 | 0.137 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 7.302702e-01 | 0.137 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.302702e-01 | 0.137 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.335990e-01 | 0.135 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 7.335990e-01 | 0.135 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 7.366545e-01 | 0.133 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 7.366955e-01 | 0.133 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 7.366955e-01 | 0.133 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 7.380452e-01 | 0.132 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 7.387665e-01 | 0.131 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.395302e-01 | 0.131 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 7.414446e-01 | 0.130 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 7.414446e-01 | 0.130 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 7.414446e-01 | 0.130 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 7.446642e-01 | 0.128 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 7.453610e-01 | 0.128 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 7.453610e-01 | 0.128 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 7.521568e-01 | 0.124 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 7.521568e-01 | 0.124 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 7.521568e-01 | 0.124 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 7.521568e-01 | 0.124 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 7.521568e-01 | 0.124 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 7.521568e-01 | 0.124 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 7.521568e-01 | 0.124 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 7.524253e-01 | 0.124 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 7.525535e-01 | 0.123 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 7.572577e-01 | 0.121 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 7.582429e-01 | 0.120 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 7.605054e-01 | 0.119 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 7.624258e-01 | 0.118 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 7.624258e-01 | 0.118 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.624258e-01 | 0.118 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 7.644689e-01 | 0.117 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 7.673388e-01 | 0.115 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.676900e-01 | 0.115 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.676900e-01 | 0.115 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 7.722699e-01 | 0.112 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 7.722699e-01 | 0.112 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 7.722699e-01 | 0.112 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.722699e-01 | 0.112 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 7.744984e-01 | 0.111 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 7.814649e-01 | 0.107 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 7.814649e-01 | 0.107 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 7.817066e-01 | 0.107 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.817066e-01 | 0.107 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 7.817066e-01 | 0.107 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 7.817066e-01 | 0.107 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 7.817066e-01 | 0.107 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 7.817066e-01 | 0.107 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 7.823677e-01 | 0.107 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 7.882418e-01 | 0.103 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 7.882418e-01 | 0.103 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 7.882418e-01 | 0.103 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 7.889135e-01 | 0.103 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 7.906549e-01 | 0.102 | 1 | 1 |
| EGFR downregulation | R-HSA-182971 | 7.907529e-01 | 0.102 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 7.907529e-01 | 0.102 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 7.907529e-01 | 0.102 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.948331e-01 | 0.100 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 7.948331e-01 | 0.100 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 7.948331e-01 | 0.100 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.982742e-01 | 0.098 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.982742e-01 | 0.098 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 7.994248e-01 | 0.097 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 8.012423e-01 | 0.096 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.044709e-01 | 0.094 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 8.050033e-01 | 0.094 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 8.074733e-01 | 0.093 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 8.077185e-01 | 0.093 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 8.077379e-01 | 0.093 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 8.077379e-01 | 0.093 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 8.077379e-01 | 0.093 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 8.077379e-01 | 0.093 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 8.077379e-01 | 0.093 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 8.147965e-01 | 0.089 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.157069e-01 | 0.088 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 8.157069e-01 | 0.088 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.157069e-01 | 0.088 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 8.157069e-01 | 0.088 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 8.212069e-01 | 0.086 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.233460e-01 | 0.084 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.233460e-01 | 0.084 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 8.233460e-01 | 0.084 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 8.233460e-01 | 0.084 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.233460e-01 | 0.084 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.233460e-01 | 0.084 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.251343e-01 | 0.083 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 8.294651e-01 | 0.081 | 1 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.306689e-01 | 0.081 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 8.306689e-01 | 0.081 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.306689e-01 | 0.081 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.306689e-01 | 0.081 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 8.339057e-01 | 0.079 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.340644e-01 | 0.079 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.376887e-01 | 0.077 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.376887e-01 | 0.077 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.376887e-01 | 0.077 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.376887e-01 | 0.077 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.444179e-01 | 0.073 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 8.444179e-01 | 0.073 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 8.444179e-01 | 0.073 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.464134e-01 | 0.072 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 8.464134e-01 | 0.072 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 8.464134e-01 | 0.072 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.508685e-01 | 0.070 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 8.508685e-01 | 0.070 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.508685e-01 | 0.070 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 8.508685e-01 | 0.070 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.508685e-01 | 0.070 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 8.513525e-01 | 0.070 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 8.557025e-01 | 0.068 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 8.561465e-01 | 0.067 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.570521e-01 | 0.067 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.570521e-01 | 0.067 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.570521e-01 | 0.067 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 8.607989e-01 | 0.065 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 8.611214e-01 | 0.065 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.629796e-01 | 0.064 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.629796e-01 | 0.064 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 8.653133e-01 | 0.063 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.653133e-01 | 0.063 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 8.682512e-01 | 0.061 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.686617e-01 | 0.061 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 8.686617e-01 | 0.061 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.686617e-01 | 0.061 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 8.696931e-01 | 0.061 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 8.705553e-01 | 0.060 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 8.709074e-01 | 0.060 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 8.711972e-01 | 0.060 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 8.725575e-01 | 0.059 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 8.739417e-01 | 0.059 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.741084e-01 | 0.058 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.741084e-01 | 0.058 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 8.749399e-01 | 0.058 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 8.753545e-01 | 0.058 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 8.780624e-01 | 0.056 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 8.780624e-01 | 0.056 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 8.780624e-01 | 0.056 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 8.793296e-01 | 0.056 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 8.820584e-01 | 0.055 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 8.822866e-01 | 0.054 | 1 | 1 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.822866e-01 | 0.054 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 8.843346e-01 | 0.053 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 8.843346e-01 | 0.053 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 8.852035e-01 | 0.053 | 1 | 1 |
| Disease | R-HSA-1643685 | 8.873191e-01 | 0.052 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 8.891323e-01 | 0.051 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 8.891323e-01 | 0.051 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 8.896898e-01 | 0.051 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.937312e-01 | 0.049 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.937312e-01 | 0.049 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 8.937312e-01 | 0.049 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 8.937312e-01 | 0.049 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 8.937312e-01 | 0.049 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 8.937312e-01 | 0.049 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 8.948001e-01 | 0.048 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 8.965445e-01 | 0.047 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.968609e-01 | 0.047 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.981396e-01 | 0.047 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.981396e-01 | 0.047 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.981396e-01 | 0.047 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.981396e-01 | 0.047 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 8.981396e-01 | 0.047 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 9.002815e-01 | 0.046 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.006349e-01 | 0.045 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 9.007915e-01 | 0.045 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.023655e-01 | 0.045 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.023655e-01 | 0.045 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.023655e-01 | 0.045 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.023655e-01 | 0.045 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 9.064162e-01 | 0.043 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.064162e-01 | 0.043 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.064162e-01 | 0.043 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.064736e-01 | 0.043 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 9.068077e-01 | 0.042 | 1 | 1 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 9.068077e-01 | 0.042 | 1 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.092028e-01 | 0.041 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 9.102992e-01 | 0.041 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 9.102992e-01 | 0.041 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.139181e-01 | 0.039 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.140212e-01 | 0.039 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.144457e-01 | 0.039 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.175890e-01 | 0.037 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.210090e-01 | 0.036 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.210090e-01 | 0.036 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.214165e-01 | 0.036 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.228664e-01 | 0.035 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 9.240770e-01 | 0.034 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 9.241137e-01 | 0.034 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.242873e-01 | 0.034 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.242873e-01 | 0.034 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 9.274297e-01 | 0.033 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 9.280155e-01 | 0.032 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.281296e-01 | 0.032 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.304418e-01 | 0.031 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.315223e-01 | 0.031 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 9.333291e-01 | 0.030 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.353058e-01 | 0.029 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.360967e-01 | 0.029 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.387496e-01 | 0.027 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 9.387496e-01 | 0.027 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.387496e-01 | 0.027 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.403904e-01 | 0.027 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.412926e-01 | 0.026 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 9.424308e-01 | 0.026 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.437301e-01 | 0.025 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.460665e-01 | 0.024 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 9.481609e-01 | 0.023 | 1 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.481609e-01 | 0.023 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 9.490274e-01 | 0.023 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 9.497742e-01 | 0.022 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.504527e-01 | 0.022 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.525104e-01 | 0.021 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.528061e-01 | 0.021 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.544828e-01 | 0.020 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.563733e-01 | 0.019 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.581854e-01 | 0.019 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.599224e-01 | 0.018 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.609018e-01 | 0.017 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.617920e-01 | 0.017 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.631831e-01 | 0.016 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.647128e-01 | 0.016 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.647128e-01 | 0.016 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.647128e-01 | 0.016 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.648569e-01 | 0.016 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.661790e-01 | 0.015 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 9.661790e-01 | 0.015 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.702225e-01 | 0.013 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.720690e-01 | 0.012 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.726462e-01 | 0.012 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.737832e-01 | 0.012 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.737832e-01 | 0.012 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.745463e-01 | 0.011 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.746485e-01 | 0.011 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.748729e-01 | 0.011 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.748729e-01 | 0.011 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.754570e-01 | 0.011 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.779719e-01 | 0.010 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.796796e-01 | 0.009 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.799944e-01 | 0.009 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.828548e-01 | 0.008 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.835679e-01 | 0.007 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.839293e-01 | 0.007 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.842896e-01 | 0.007 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.849065e-01 | 0.007 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.877958e-01 | 0.005 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.879752e-01 | 0.005 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.898111e-01 | 0.004 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.918311e-01 | 0.004 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.926949e-01 | 0.003 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.945601e-01 | 0.002 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.945919e-01 | 0.002 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.970026e-01 | 0.001 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.972474e-01 | 0.001 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.977755e-01 | 0.001 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.980424e-01 | 0.001 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.982535e-01 | 0.001 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.982647e-01 | 0.001 | 0 | 0 |
| Translation | R-HSA-72766 | 9.986501e-01 | 0.001 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.990105e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.992006e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.992660e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.995514e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.995924e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.996295e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.998355e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999472e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999837e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999933e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999959e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999967e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999975e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999987e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999998e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| DNA methylation | R-HSA-5334118 | 1.110223e-16 | 15.955 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.110223e-16 | 15.955 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.110223e-16 | 15.955 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.110223e-16 | 15.955 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.110223e-16 | 15.955 | 1 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.110223e-16 | 15.955 | 1 | 0 |
| Axon guidance | R-HSA-422475 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 1 | 0 |
| Nervous system development | R-HSA-9675108 | 1.110223e-16 | 15.955 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.110223e-16 | 15.955 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.110223e-16 | 15.955 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.110223e-16 | 15.955 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.110223e-15 | 14.955 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.332268e-15 | 14.875 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.998401e-15 | 14.699 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 4.440892e-15 | 14.353 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 4.440892e-15 | 14.353 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 6.217249e-15 | 14.206 | 1 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 7.882583e-15 | 14.103 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 8.437695e-15 | 14.074 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.043610e-14 | 13.981 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.021405e-14 | 13.991 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.043610e-14 | 13.981 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 9.658940e-15 | 14.015 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.354472e-14 | 13.868 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.409983e-14 | 13.851 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.487699e-14 | 13.827 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.521006e-14 | 13.818 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.687539e-14 | 13.773 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.687539e-14 | 13.773 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.687539e-14 | 13.773 | 1 | 0 |
| HCMV Infection | R-HSA-9609646 | 2.309264e-14 | 13.637 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 2.386980e-14 | 13.622 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.497203e-14 | 13.456 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 4.274359e-14 | 13.369 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.384582e-14 | 13.269 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 5.828671e-14 | 13.234 | 1 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 6.383782e-14 | 13.195 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 6.572520e-14 | 13.182 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 6.716849e-14 | 13.173 | 1 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.100231e-13 | 12.959 | 1 | 1 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.150191e-13 | 12.939 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.161293e-13 | 12.935 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.207923e-13 | 12.918 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.207923e-13 | 12.918 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.245670e-13 | 12.905 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.372236e-13 | 12.863 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 1.550982e-13 | 12.809 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.850742e-13 | 12.733 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.988409e-13 | 12.701 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.138290e-13 | 12.670 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 2.774447e-13 | 12.557 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.740030e-13 | 12.562 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 2.957634e-13 | 12.529 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.037570e-13 | 12.517 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 3.299583e-13 | 12.482 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 3.728129e-13 | 12.429 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.764766e-13 | 12.424 | 1 | 1 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 4.116707e-13 | 12.385 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.619638e-13 | 12.335 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 4.818368e-13 | 12.317 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 5.231371e-13 | 12.281 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 5.720979e-13 | 12.243 | 1 | 1 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 6.800116e-13 | 12.167 | 1 | 1 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 6.888934e-13 | 12.162 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 7.348566e-13 | 12.134 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 7.149836e-13 | 12.146 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 7.547296e-13 | 12.122 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 9.754419e-13 | 12.011 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.229017e-12 | 11.910 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.231348e-12 | 11.910 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.648903e-12 | 11.783 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.659450e-12 | 11.780 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.380429e-12 | 11.623 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.770117e-12 | 11.558 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.877809e-12 | 11.541 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 2.978395e-12 | 11.526 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 3.195333e-12 | 11.495 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.286260e-12 | 11.483 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.591571e-12 | 11.445 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 3.777645e-12 | 11.423 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 4.055867e-12 | 11.392 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 4.261147e-12 | 11.370 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 4.324208e-12 | 11.364 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 4.324208e-12 | 11.364 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.564682e-12 | 11.341 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 5.274892e-12 | 11.278 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 5.392797e-12 | 11.268 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 5.392797e-12 | 11.268 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 5.640821e-12 | 11.249 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 6.542877e-12 | 11.184 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 6.542877e-12 | 11.184 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 6.171841e-12 | 11.210 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 6.861289e-12 | 11.164 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 7.392309e-12 | 11.131 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 8.357981e-12 | 11.078 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.085909e-11 | 10.964 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.318190e-11 | 10.880 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.313616e-11 | 10.882 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.356992e-11 | 10.867 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.490219e-11 | 10.827 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.578093e-11 | 10.802 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.845601e-11 | 10.734 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.024858e-11 | 10.694 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.917011e-11 | 10.717 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.941569e-11 | 10.712 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.099532e-11 | 10.678 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.170197e-11 | 10.664 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.366540e-11 | 10.626 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 2.428724e-11 | 10.615 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.629164e-11 | 10.580 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.843348e-11 | 10.546 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.843348e-11 | 10.546 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 2.914646e-11 | 10.535 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 3.075518e-11 | 10.512 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 3.464296e-11 | 10.460 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 4.015355e-11 | 10.396 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.083245e-11 | 10.389 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 4.243028e-11 | 10.372 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 4.576151e-11 | 10.339 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 6.395484e-11 | 10.194 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 6.113576e-11 | 10.214 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 7.127299e-11 | 10.147 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 7.418310e-11 | 10.130 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.500056e-11 | 10.022 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.008836e-10 | 9.996 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.196938e-10 | 9.922 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.407201e-10 | 9.852 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.414776e-10 | 9.849 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.485042e-10 | 9.828 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.552635e-10 | 9.809 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.627826e-10 | 9.788 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.629862e-10 | 9.788 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.046620e-10 | 9.689 | 0 | 0 |
| Immune System | R-HSA-168256 | 2.105207e-10 | 9.677 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.629666e-10 | 9.580 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.633780e-10 | 9.579 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.865900e-10 | 9.543 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.944510e-10 | 9.531 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.052832e-10 | 9.515 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.089774e-10 | 9.510 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.197851e-10 | 9.495 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 3.768502e-10 | 9.424 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.306128e-10 | 9.366 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 4.715390e-10 | 9.326 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 5.633842e-10 | 9.249 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 6.718034e-10 | 9.173 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 6.813080e-10 | 9.167 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 6.813080e-10 | 9.167 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.307739e-09 | 8.883 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.336046e-09 | 8.874 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.373058e-09 | 8.862 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.647363e-09 | 8.783 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.952038e-09 | 8.710 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.044432e-09 | 8.689 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.355023e-09 | 8.628 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.472248e-09 | 8.607 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 2.592583e-09 | 8.586 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.636185e-09 | 8.579 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 3.002416e-09 | 8.523 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 4.150827e-09 | 8.382 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.445025e-09 | 8.352 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.445025e-09 | 8.352 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 5.112012e-09 | 8.291 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 6.406369e-09 | 8.193 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 6.729811e-09 | 8.172 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 7.328979e-09 | 8.135 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.083279e-09 | 8.042 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.009583e-08 | 7.996 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.092067e-08 | 7.962 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.343935e-08 | 7.872 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.560287e-08 | 7.807 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.705268e-08 | 7.768 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.817485e-08 | 7.741 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.817485e-08 | 7.741 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 2.151900e-08 | 7.667 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.273064e-08 | 7.643 | 0 | 0 |
| Translation | R-HSA-72766 | 2.382472e-08 | 7.623 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.707670e-08 | 7.567 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 2.537609e-08 | 7.596 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 2.655121e-08 | 7.576 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.907710e-08 | 7.536 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.167242e-08 | 7.499 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 3.401798e-08 | 7.468 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 4.062152e-08 | 7.391 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 4.590195e-08 | 7.338 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 5.374323e-08 | 7.270 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 5.553017e-08 | 7.255 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 6.030878e-08 | 7.220 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 6.345210e-08 | 7.198 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 7.595039e-08 | 7.119 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 7.595039e-08 | 7.119 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 8.659383e-08 | 7.063 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.161518e-08 | 7.038 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.027669e-07 | 6.988 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.141296e-07 | 6.943 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.155065e-07 | 6.937 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.400648e-07 | 6.854 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.404291e-07 | 6.853 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.404291e-07 | 6.853 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.404291e-07 | 6.853 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.449089e-07 | 6.839 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.703668e-07 | 6.769 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.746390e-07 | 6.758 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.747655e-07 | 6.758 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.819642e-07 | 6.740 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.939887e-07 | 6.712 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.961424e-07 | 6.707 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.458221e-07 | 6.609 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.611542e-07 | 6.583 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 2.950035e-07 | 6.530 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 2.990402e-07 | 6.524 | 0 | 0 |
| Kinesins | R-HSA-983189 | 3.114612e-07 | 6.507 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 3.526083e-07 | 6.453 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 3.526083e-07 | 6.453 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 4.547657e-07 | 6.342 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 5.064844e-07 | 6.295 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 5.138883e-07 | 6.289 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 5.410746e-07 | 6.267 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 5.484461e-07 | 6.261 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 5.484461e-07 | 6.261 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 5.484461e-07 | 6.261 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 5.484461e-07 | 6.261 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 6.440715e-07 | 6.191 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 6.825245e-07 | 6.166 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 7.285737e-07 | 6.138 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 8.305426e-07 | 6.081 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 9.583409e-07 | 6.018 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.897569e-07 | 6.004 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.293173e-06 | 5.888 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.307759e-06 | 5.883 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 1.341898e-06 | 5.872 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.452975e-06 | 5.838 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.511587e-06 | 5.821 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.721334e-06 | 5.764 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.843330e-06 | 5.734 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.849090e-06 | 5.733 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.857848e-06 | 5.731 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.902957e-06 | 5.721 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 2.124429e-06 | 5.673 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 2.242926e-06 | 5.649 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.489476e-06 | 5.604 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 2.489476e-06 | 5.604 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.780777e-06 | 5.556 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.693788e-06 | 5.433 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 4.063301e-06 | 5.391 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.349944e-06 | 5.362 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 4.561533e-06 | 5.341 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 4.917063e-06 | 5.308 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 4.917063e-06 | 5.308 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 4.917063e-06 | 5.308 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 6.390679e-06 | 5.194 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 6.418264e-06 | 5.193 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 8.374553e-06 | 5.077 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 8.692096e-06 | 5.061 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 8.844174e-06 | 5.053 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.075670e-06 | 5.042 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 9.985451e-06 | 5.001 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 9.985451e-06 | 5.001 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.030162e-05 | 4.987 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.213580e-05 | 4.916 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.213580e-05 | 4.916 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.215150e-05 | 4.915 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.230437e-05 | 4.910 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.326481e-05 | 4.877 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.465054e-05 | 4.834 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.509881e-05 | 4.821 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.572893e-05 | 4.803 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.643114e-05 | 4.784 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.902605e-05 | 4.721 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.883186e-05 | 4.725 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.127652e-05 | 4.672 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 2.263022e-05 | 4.645 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.571042e-05 | 4.590 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.571042e-05 | 4.590 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.589813e-05 | 4.587 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 2.703163e-05 | 4.568 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.250321e-05 | 4.488 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.444366e-05 | 4.463 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 3.717834e-05 | 4.430 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.717834e-05 | 4.430 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 3.723909e-05 | 4.429 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 4.089503e-05 | 4.388 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 4.172736e-05 | 4.380 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 4.391534e-05 | 4.357 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 4.435647e-05 | 4.353 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.579050e-05 | 4.339 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 4.893250e-05 | 4.310 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.903489e-05 | 4.309 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 5.182976e-05 | 4.285 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 5.182976e-05 | 4.285 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 5.182976e-05 | 4.285 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 5.195257e-05 | 4.284 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.448120e-05 | 4.264 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 5.501934e-05 | 4.259 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 5.868839e-05 | 4.231 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 5.868839e-05 | 4.231 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 6.605686e-05 | 4.180 | 1 | 1 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 6.605686e-05 | 4.180 | 1 | 0 |
| PECAM1 interactions | R-HSA-210990 | 6.862262e-05 | 4.164 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 7.486181e-05 | 4.126 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 7.532663e-05 | 4.123 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.532663e-05 | 4.123 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.532663e-05 | 4.123 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 7.805473e-05 | 4.108 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 8.082731e-05 | 4.092 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 8.082731e-05 | 4.092 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 8.236986e-05 | 4.084 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 9.346905e-05 | 4.029 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 9.391827e-05 | 4.027 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 9.517784e-05 | 4.021 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.357506e-04 | 3.867 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.357506e-04 | 3.867 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.131516e-04 | 3.946 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.095184e-04 | 3.961 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.221904e-04 | 3.913 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.370536e-04 | 3.863 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.375058e-04 | 3.862 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.418185e-04 | 3.848 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.635283e-04 | 3.786 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.873266e-04 | 3.727 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.873266e-04 | 3.727 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.950916e-04 | 3.710 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.958887e-04 | 3.708 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 2.122795e-04 | 3.673 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 2.175346e-04 | 3.662 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.189659e-04 | 3.660 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.334047e-04 | 3.632 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.361508e-04 | 3.627 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 2.482268e-04 | 3.605 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.641358e-04 | 3.578 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.641358e-04 | 3.578 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.923850e-04 | 3.534 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.996752e-04 | 3.523 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.996752e-04 | 3.523 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 3.154462e-04 | 3.501 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.264304e-04 | 3.486 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 3.296221e-04 | 3.482 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 3.363766e-04 | 3.473 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.379985e-04 | 3.471 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 3.510566e-04 | 3.455 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 3.510566e-04 | 3.455 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 3.612546e-04 | 3.442 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 3.747521e-04 | 3.426 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.747521e-04 | 3.426 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.747521e-04 | 3.426 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.747521e-04 | 3.426 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.843497e-04 | 3.415 | 1 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 3.943151e-04 | 3.404 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 4.044184e-04 | 3.393 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 4.044184e-04 | 3.393 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 4.471407e-04 | 3.350 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 4.481525e-04 | 3.349 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.481525e-04 | 3.349 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 4.610195e-04 | 3.336 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 4.641706e-04 | 3.333 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 4.727819e-04 | 3.325 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 4.738781e-04 | 3.324 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 4.738781e-04 | 3.324 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 4.832429e-04 | 3.316 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 4.832429e-04 | 3.316 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 4.832429e-04 | 3.316 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 5.217291e-04 | 3.283 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 5.217291e-04 | 3.283 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 5.217291e-04 | 3.283 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 5.739543e-04 | 3.241 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 5.885245e-04 | 3.230 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.885245e-04 | 3.230 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.909449e-04 | 3.228 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 6.049287e-04 | 3.218 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 6.303996e-04 | 3.200 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 6.307679e-04 | 3.200 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 6.307679e-04 | 3.200 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 6.479219e-04 | 3.188 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 6.479219e-04 | 3.188 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.763882e-04 | 3.170 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 6.782413e-04 | 3.169 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 6.782413e-04 | 3.169 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 6.937583e-04 | 3.159 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 6.937583e-04 | 3.159 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 7.271713e-04 | 3.138 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 9.419767e-04 | 3.026 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.005199e-03 | 2.998 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.005199e-03 | 2.998 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 9.997034e-04 | 3.000 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 7.971176e-04 | 3.098 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 9.321807e-04 | 3.030 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 7.743188e-04 | 3.111 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 9.217862e-04 | 3.035 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.889030e-04 | 3.005 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 7.971176e-04 | 3.098 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 9.832667e-04 | 3.007 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 8.061403e-04 | 3.094 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 8.039521e-04 | 3.095 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 1.084981e-03 | 2.965 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.084981e-03 | 2.965 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.137948e-03 | 2.944 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.137948e-03 | 2.944 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.137948e-03 | 2.944 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.137948e-03 | 2.944 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.199523e-03 | 2.921 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.199523e-03 | 2.921 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.216333e-03 | 2.915 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 1.257146e-03 | 2.901 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.257146e-03 | 2.901 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.394278e-03 | 2.856 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 1.450380e-03 | 2.839 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 1.450380e-03 | 2.839 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.450380e-03 | 2.839 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 1.450380e-03 | 2.839 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.450380e-03 | 2.839 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.461811e-03 | 2.835 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.464192e-03 | 2.834 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 1.491883e-03 | 2.826 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.587877e-03 | 2.799 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.666459e-03 | 2.778 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 1.667431e-03 | 2.778 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.667431e-03 | 2.778 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.667431e-03 | 2.778 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.704469e-03 | 2.768 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.734571e-03 | 2.761 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.751630e-03 | 2.757 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.769592e-03 | 2.752 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.841077e-03 | 2.735 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.897854e-03 | 2.722 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.907232e-03 | 2.720 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.945826e-03 | 2.711 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.950625e-03 | 2.710 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 2.070288e-03 | 2.684 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.070288e-03 | 2.684 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 2.070288e-03 | 2.684 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.095135e-03 | 2.679 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 2.095135e-03 | 2.679 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 2.095135e-03 | 2.679 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.174615e-03 | 2.663 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 2.269696e-03 | 2.644 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 2.269696e-03 | 2.644 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 2.304266e-03 | 2.637 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.327286e-03 | 2.633 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.392706e-03 | 2.621 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 2.392706e-03 | 2.621 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 2.392706e-03 | 2.621 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.392706e-03 | 2.621 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.392706e-03 | 2.621 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 2.392706e-03 | 2.621 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 2.457672e-03 | 2.609 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 2.457672e-03 | 2.609 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.470588e-03 | 2.607 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.470588e-03 | 2.607 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 2.470588e-03 | 2.607 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 2.514914e-03 | 2.599 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 2.565408e-03 | 2.591 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.628597e-03 | 2.580 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 2.743525e-03 | 2.562 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 2.797192e-03 | 2.553 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 2.797192e-03 | 2.553 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 2.797192e-03 | 2.553 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 2.797192e-03 | 2.553 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.797192e-03 | 2.553 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.827162e-03 | 2.549 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 2.899191e-03 | 2.538 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 2.975184e-03 | 2.526 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.975184e-03 | 2.526 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 3.003102e-03 | 2.522 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.027261e-03 | 2.519 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 3.116671e-03 | 2.506 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 3.146173e-03 | 2.502 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.156525e-03 | 2.501 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 3.471847e-03 | 2.459 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 3.471847e-03 | 2.459 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.515483e-03 | 2.454 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 3.550741e-03 | 2.450 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 3.748892e-03 | 2.426 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 3.748892e-03 | 2.426 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 3.748892e-03 | 2.426 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 3.748892e-03 | 2.426 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.964474e-03 | 2.402 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 3.964474e-03 | 2.402 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 3.964474e-03 | 2.402 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 3.982036e-03 | 2.400 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 3.982036e-03 | 2.400 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.982036e-03 | 2.400 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 3.982036e-03 | 2.400 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 3.982036e-03 | 2.400 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 4.114296e-03 | 2.386 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.159526e-03 | 2.381 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 4.452656e-03 | 2.351 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 4.508338e-03 | 2.346 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.833476e-03 | 2.316 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.347610e-03 | 2.197 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 6.347610e-03 | 2.197 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 4.964880e-03 | 2.304 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 5.666200e-03 | 2.247 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 6.331059e-03 | 2.199 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.347610e-03 | 2.197 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 6.774470e-03 | 2.169 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 6.952958e-03 | 2.158 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 6.363716e-03 | 2.196 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 5.331658e-03 | 2.273 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 4.912471e-03 | 2.309 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 5.533485e-03 | 2.257 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.353435e-03 | 2.271 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.353435e-03 | 2.271 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 6.123433e-03 | 2.213 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 6.743979e-03 | 2.171 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 6.743979e-03 | 2.171 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 6.621830e-03 | 2.179 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.283761e-03 | 2.138 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 4.912471e-03 | 2.309 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 4.912471e-03 | 2.309 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 7.283761e-03 | 2.138 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 6.774470e-03 | 2.169 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 6.774470e-03 | 2.169 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 7.261388e-03 | 2.139 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 6.169880e-03 | 2.210 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 5.167726e-03 | 2.287 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 5.598582e-03 | 2.252 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 7.492167e-03 | 2.125 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 7.492167e-03 | 2.125 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 7.697071e-03 | 2.114 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 7.697071e-03 | 2.114 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 7.697071e-03 | 2.114 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 7.697071e-03 | 2.114 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 8.110531e-03 | 2.091 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 8.231973e-03 | 2.084 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 8.536039e-03 | 2.069 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 8.773044e-03 | 2.057 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 8.773044e-03 | 2.057 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 8.773044e-03 | 2.057 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 8.905421e-03 | 2.050 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.030630e-03 | 2.044 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.030630e-03 | 2.044 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.043231e-03 | 2.044 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.043231e-03 | 2.044 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.092260e-03 | 2.041 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 9.299984e-03 | 2.032 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 9.395612e-03 | 2.027 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 9.395612e-03 | 2.027 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.395612e-03 | 2.027 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 9.453747e-03 | 2.024 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 9.560267e-03 | 2.020 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 9.912694e-03 | 2.004 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.912694e-03 | 2.004 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 9.912694e-03 | 2.004 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.019768e-02 | 1.991 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 1.019768e-02 | 1.991 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.060261e-02 | 1.975 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.084275e-02 | 1.965 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.085712e-02 | 1.964 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 1.132970e-02 | 1.946 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.145223e-02 | 1.941 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 1.145223e-02 | 1.941 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 1.145223e-02 | 1.941 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.183579e-02 | 1.927 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.183579e-02 | 1.927 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.187386e-02 | 1.925 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.191556e-02 | 1.924 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 1.199987e-02 | 1.921 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 1.224930e-02 | 1.912 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 1.224930e-02 | 1.912 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.266555e-02 | 1.897 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 1.266555e-02 | 1.897 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.266555e-02 | 1.897 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 1.266555e-02 | 1.897 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.289417e-02 | 1.890 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.289417e-02 | 1.890 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.289417e-02 | 1.890 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.289417e-02 | 1.890 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.325764e-02 | 1.878 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 1.370363e-02 | 1.863 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.370363e-02 | 1.863 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.436392e-02 | 1.843 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 1.480899e-02 | 1.829 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 1.480899e-02 | 1.829 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 1.487712e-02 | 1.827 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.497891e-02 | 1.825 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 1.521627e-02 | 1.818 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.533833e-02 | 1.814 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.540371e-02 | 1.812 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.540371e-02 | 1.812 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.540371e-02 | 1.812 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.602426e-02 | 1.795 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 1.602426e-02 | 1.795 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.602426e-02 | 1.795 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.602426e-02 | 1.795 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.602426e-02 | 1.795 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.602426e-02 | 1.795 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.602426e-02 | 1.795 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.602426e-02 | 1.795 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.602426e-02 | 1.795 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.602426e-02 | 1.795 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.602426e-02 | 1.795 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.602426e-02 | 1.795 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 1.621780e-02 | 1.790 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.621780e-02 | 1.790 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 1.621780e-02 | 1.790 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.622230e-02 | 1.790 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.622230e-02 | 1.790 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.622230e-02 | 1.790 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.628256e-02 | 1.788 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.628256e-02 | 1.788 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.628256e-02 | 1.788 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.630217e-02 | 1.788 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.653426e-02 | 1.782 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.729263e-02 | 1.762 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.747109e-02 | 1.758 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.772856e-02 | 1.751 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.831441e-02 | 1.737 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.831441e-02 | 1.737 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 1.900333e-02 | 1.721 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 1.900333e-02 | 1.721 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.900333e-02 | 1.721 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.900333e-02 | 1.721 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.900333e-02 | 1.721 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.933062e-02 | 1.714 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 1.971414e-02 | 1.705 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.022139e-02 | 1.694 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.041964e-02 | 1.690 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.041964e-02 | 1.690 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 2.041964e-02 | 1.690 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.041964e-02 | 1.690 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 2.112252e-02 | 1.675 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.206754e-02 | 1.656 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.206754e-02 | 1.656 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 2.206754e-02 | 1.656 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 2.206754e-02 | 1.656 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 2.213798e-02 | 1.655 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.213798e-02 | 1.655 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 2.427224e-02 | 1.615 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.436327e-02 | 1.613 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 2.443021e-02 | 1.612 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 2.474728e-02 | 1.606 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.494834e-02 | 1.603 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 2.508037e-02 | 1.601 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.508037e-02 | 1.601 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.541647e-02 | 1.595 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.541647e-02 | 1.595 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 2.673870e-02 | 1.573 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 2.675084e-02 | 1.573 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.705665e-02 | 1.568 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 2.754622e-02 | 1.560 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.754622e-02 | 1.560 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.905496e-02 | 1.537 | 0 | 0 |
| S Phase | R-HSA-69242 | 3.105023e-02 | 1.508 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.150291e-02 | 1.502 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 3.150291e-02 | 1.502 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 3.167408e-02 | 1.499 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.270361e-02 | 1.485 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 3.298659e-02 | 1.482 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 3.298659e-02 | 1.482 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 3.298659e-02 | 1.482 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 3.330516e-02 | 1.477 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 3.372737e-02 | 1.472 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 3.388160e-02 | 1.470 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 3.388160e-02 | 1.470 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 3.451555e-02 | 1.462 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.451555e-02 | 1.462 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 4.657495e-02 | 1.332 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 4.471395e-02 | 1.350 | 0 | 0 |
| IRS activation | R-HSA-74713 | 4.471395e-02 | 1.350 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.663290e-02 | 1.247 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.951401e-02 | 1.158 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 6.951401e-02 | 1.158 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 4.217962e-02 | 1.375 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.217962e-02 | 1.375 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 4.889340e-02 | 1.311 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 5.609484e-02 | 1.251 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 6.376898e-02 | 1.195 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 6.376898e-02 | 1.195 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 4.173783e-02 | 1.379 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 4.655890e-02 | 1.332 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 4.449791e-02 | 1.352 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 4.824904e-02 | 1.317 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 4.070509e-02 | 1.390 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.361934e-02 | 1.360 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.471395e-02 | 1.350 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 3.596636e-02 | 1.444 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 5.789986e-02 | 1.237 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.721379e-02 | 1.429 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.663290e-02 | 1.247 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 5.269760e-02 | 1.278 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 6.279080e-02 | 1.202 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 4.142115e-02 | 1.383 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 4.142115e-02 | 1.383 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 4.142115e-02 | 1.383 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 4.471395e-02 | 1.350 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 6.951401e-02 | 1.158 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 6.489106e-02 | 1.188 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 6.376898e-02 | 1.195 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.891251e-02 | 1.230 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 6.790871e-02 | 1.168 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.235692e-02 | 1.373 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 3.721379e-02 | 1.429 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 6.795991e-02 | 1.168 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 6.878175e-02 | 1.163 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 6.376898e-02 | 1.195 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 6.545590e-02 | 1.184 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 4.173783e-02 | 1.379 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 5.481172e-02 | 1.261 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.906870e-02 | 1.408 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 3.599200e-02 | 1.444 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.906870e-02 | 1.408 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.906870e-02 | 1.408 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.711549e-02 | 1.430 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.891251e-02 | 1.230 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 4.849516e-02 | 1.314 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.988940e-02 | 1.223 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 4.537726e-02 | 1.343 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 4.042418e-02 | 1.393 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 4.641161e-02 | 1.333 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 5.167614e-02 | 1.287 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 4.070509e-02 | 1.390 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 3.590581e-02 | 1.445 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.321098e-02 | 1.199 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 4.471395e-02 | 1.350 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 5.663290e-02 | 1.247 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 5.167614e-02 | 1.287 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 6.878175e-02 | 1.163 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.001211e-02 | 1.222 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 5.710549e-02 | 1.243 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.070509e-02 | 1.390 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.361934e-02 | 1.360 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 5.710549e-02 | 1.243 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 5.663290e-02 | 1.247 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 5.609484e-02 | 1.251 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 5.878579e-02 | 1.231 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 6.653640e-02 | 1.177 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 4.695752e-02 | 1.328 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 5.167614e-02 | 1.287 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 3.739996e-02 | 1.427 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.361934e-02 | 1.360 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.906870e-02 | 1.408 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 3.721379e-02 | 1.429 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 5.710549e-02 | 1.243 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.590581e-02 | 1.445 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 3.967069e-02 | 1.402 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 5.824190e-02 | 1.235 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 5.350261e-02 | 1.272 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 7.024564e-02 | 1.153 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.024564e-02 | 1.153 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 7.155766e-02 | 1.145 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 7.155766e-02 | 1.145 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 7.155766e-02 | 1.145 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 7.189912e-02 | 1.143 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 7.299586e-02 | 1.137 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 7.505607e-02 | 1.125 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 7.505607e-02 | 1.125 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 7.505607e-02 | 1.125 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.505607e-02 | 1.125 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 7.505607e-02 | 1.125 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 7.505607e-02 | 1.125 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 7.505607e-02 | 1.125 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 7.678092e-02 | 1.115 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.734088e-02 | 1.112 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.031972e-02 | 1.095 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 8.046710e-02 | 1.094 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 8.160850e-02 | 1.088 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 8.160850e-02 | 1.088 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 8.220423e-02 | 1.085 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.220423e-02 | 1.085 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 8.324207e-02 | 1.080 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 8.324207e-02 | 1.080 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 8.324207e-02 | 1.080 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 8.324207e-02 | 1.080 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 8.324207e-02 | 1.080 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 8.399255e-02 | 1.076 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 8.531509e-02 | 1.069 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.843308e-02 | 1.053 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 8.853550e-02 | 1.053 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.888290e-02 | 1.051 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 8.910145e-02 | 1.050 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 8.945357e-02 | 1.048 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 8.945357e-02 | 1.048 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 8.959207e-02 | 1.048 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 9.098336e-02 | 1.041 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 9.098336e-02 | 1.041 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH3 | R-HSA-5632927 | 9.098336e-02 | 1.041 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 9.098336e-02 | 1.041 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 9.098336e-02 | 1.041 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 9.098336e-02 | 1.041 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 9.098336e-02 | 1.041 | 0 | 0 |
| Activation and oligomerization of BAK protein | R-HSA-111452 | 9.098336e-02 | 1.041 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 9.098336e-02 | 1.041 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 9.098336e-02 | 1.041 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.182937e-02 | 1.037 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.182937e-02 | 1.037 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.257239e-02 | 1.034 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 9.392528e-02 | 1.027 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 9.638329e-02 | 1.016 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 9.771047e-02 | 1.010 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 9.771047e-02 | 1.010 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 9.771047e-02 | 1.010 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 9.771047e-02 | 1.010 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 9.883820e-02 | 1.005 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 9.883820e-02 | 1.005 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 9.883820e-02 | 1.005 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 9.883820e-02 | 1.005 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 1.028716e-01 | 0.988 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 1.044598e-01 | 0.981 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.044598e-01 | 0.981 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 1.058459e-01 | 0.975 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.086787e-01 | 0.964 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.086787e-01 | 0.964 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.099482e-01 | 0.959 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.099482e-01 | 0.959 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.099482e-01 | 0.959 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.099482e-01 | 0.959 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.099482e-01 | 0.959 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.099482e-01 | 0.959 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 1.099482e-01 | 0.959 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 1.122273e-01 | 0.950 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.128207e-01 | 0.948 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.128207e-01 | 0.948 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 1.128207e-01 | 0.948 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 1.128207e-01 | 0.948 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.128207e-01 | 0.948 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.128207e-01 | 0.948 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 1.128207e-01 | 0.948 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.155813e-01 | 0.937 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.155813e-01 | 0.937 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 1.161601e-01 | 0.935 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.203340e-01 | 0.920 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 1.205278e-01 | 0.919 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 1.205278e-01 | 0.919 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.209696e-01 | 0.917 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 1.209696e-01 | 0.917 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 1.255280e-01 | 0.901 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.263870e-01 | 0.898 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 1.263870e-01 | 0.898 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 1.272716e-01 | 0.895 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 1.284817e-01 | 0.891 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.284817e-01 | 0.891 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.284817e-01 | 0.891 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.284817e-01 | 0.891 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.284817e-01 | 0.891 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.284817e-01 | 0.891 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 1.284817e-01 | 0.891 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 1.284817e-01 | 0.891 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.284817e-01 | 0.891 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 1.288081e-01 | 0.890 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 1.291679e-01 | 0.889 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 1.291679e-01 | 0.889 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.291679e-01 | 0.889 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 1.333236e-01 | 0.875 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 1.333259e-01 | 0.875 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 1.333259e-01 | 0.875 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 1.333259e-01 | 0.875 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 1.333259e-01 | 0.875 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 1.333259e-01 | 0.875 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 1.333259e-01 | 0.875 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 1.333259e-01 | 0.875 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 1.333259e-01 | 0.875 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.333259e-01 | 0.875 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.346868e-01 | 0.871 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 1.346868e-01 | 0.871 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 1.346868e-01 | 0.871 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 1.346868e-01 | 0.871 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 1.346868e-01 | 0.871 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.387470e-01 | 0.858 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 1.399299e-01 | 0.854 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.399299e-01 | 0.854 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 1.399299e-01 | 0.854 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.432017e-01 | 0.844 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.446096e-01 | 0.840 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.446096e-01 | 0.840 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 1.446096e-01 | 0.840 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.446096e-01 | 0.840 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 1.484500e-01 | 0.828 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.492421e-01 | 0.826 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 1.509809e-01 | 0.821 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 1.509809e-01 | 0.821 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 1.519224e-01 | 0.818 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 1.519224e-01 | 0.818 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.522716e-01 | 0.817 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.596334e-01 | 0.797 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.596334e-01 | 0.797 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 1.611271e-01 | 0.793 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.611271e-01 | 0.793 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.611271e-01 | 0.793 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.611271e-01 | 0.793 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.622987e-01 | 0.790 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 1.680842e-01 | 0.774 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 1.699408e-01 | 0.770 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.736985e-01 | 0.760 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.736985e-01 | 0.760 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.736985e-01 | 0.760 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 1.736985e-01 | 0.760 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 1.736985e-01 | 0.760 | 0 | 0 |
| Defective AHCY causes HMAHCHD | R-HSA-5578997 | 1.736985e-01 | 0.760 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 1.736985e-01 | 0.760 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.736985e-01 | 0.760 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 1.736985e-01 | 0.760 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 1.736985e-01 | 0.760 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 1.738610e-01 | 0.760 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.779631e-01 | 0.750 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.779631e-01 | 0.750 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.779631e-01 | 0.750 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.779631e-01 | 0.750 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.779631e-01 | 0.750 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.779631e-01 | 0.750 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.779631e-01 | 0.750 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 1.779631e-01 | 0.750 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 1.790092e-01 | 0.747 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.792183e-01 | 0.747 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 1.792183e-01 | 0.747 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.856461e-01 | 0.731 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 1.856461e-01 | 0.731 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 1.856461e-01 | 0.731 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 1.856461e-01 | 0.731 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.879599e-01 | 0.726 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.886610e-01 | 0.724 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.886610e-01 | 0.724 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.886610e-01 | 0.724 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.886610e-01 | 0.724 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.932857e-01 | 0.714 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 1.934279e-01 | 0.713 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.950521e-01 | 0.710 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 1.950521e-01 | 0.710 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.950521e-01 | 0.710 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 1.950521e-01 | 0.710 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.950521e-01 | 0.710 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.950521e-01 | 0.710 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.976323e-01 | 0.704 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 1.988262e-01 | 0.702 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 1.996705e-01 | 0.700 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 1.999614e-01 | 0.699 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 2.079998e-01 | 0.682 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 2.080032e-01 | 0.682 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 2.086746e-01 | 0.681 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.097986e-01 | 0.678 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 2.097986e-01 | 0.678 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 2.121928e-01 | 0.673 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 2.121928e-01 | 0.673 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 2.121928e-01 | 0.673 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 2.121928e-01 | 0.673 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 2.121928e-01 | 0.673 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 2.121928e-01 | 0.673 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 2.121928e-01 | 0.673 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.123343e-01 | 0.673 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.123343e-01 | 0.673 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 2.123343e-01 | 0.673 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.154333e-01 | 0.667 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 2.221242e-01 | 0.653 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 2.221242e-01 | 0.653 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 2.245851e-01 | 0.649 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 2.278738e-01 | 0.642 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.297545e-01 | 0.639 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.297545e-01 | 0.639 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 2.297545e-01 | 0.639 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.297545e-01 | 0.639 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 2.297545e-01 | 0.639 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.297545e-01 | 0.639 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 2.297545e-01 | 0.639 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 2.297545e-01 | 0.639 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 2.345888e-01 | 0.630 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 2.345888e-01 | 0.630 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 2.345888e-01 | 0.630 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 2.354598e-01 | 0.628 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 2.441907e-01 | 0.612 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.460043e-01 | 0.609 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 2.471730e-01 | 0.607 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 2.471730e-01 | 0.607 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 2.471730e-01 | 0.607 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 2.472626e-01 | 0.607 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 2.472626e-01 | 0.607 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.472626e-01 | 0.607 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 2.472626e-01 | 0.607 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 2.472626e-01 | 0.607 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 2.472626e-01 | 0.607 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.472626e-01 | 0.607 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 2.481995e-01 | 0.605 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.488960e-01 | 0.604 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.488960e-01 | 0.604 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 2.488960e-01 | 0.604 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.488960e-01 | 0.604 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 2.488960e-01 | 0.604 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 2.488960e-01 | 0.604 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 2.488960e-01 | 0.604 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.488960e-01 | 0.604 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.488960e-01 | 0.604 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.488960e-01 | 0.604 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.488960e-01 | 0.604 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 2.492740e-01 | 0.603 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 2.648126e-01 | 0.577 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.648126e-01 | 0.577 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 2.648126e-01 | 0.577 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 2.648126e-01 | 0.577 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 2.648126e-01 | 0.577 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 2.726241e-01 | 0.564 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 2.726241e-01 | 0.564 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 2.785494e-01 | 0.555 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 2.815561e-01 | 0.550 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 2.823627e-01 | 0.549 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 2.823627e-01 | 0.549 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 2.823627e-01 | 0.549 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.838914e-01 | 0.547 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.838914e-01 | 0.547 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.838914e-01 | 0.547 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.838914e-01 | 0.547 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 2.838914e-01 | 0.547 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 2.838914e-01 | 0.547 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 2.838914e-01 | 0.547 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 2.838914e-01 | 0.547 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.838914e-01 | 0.547 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 2.838914e-01 | 0.547 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 2.838914e-01 | 0.547 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 2.838914e-01 | 0.547 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.854549e-01 | 0.544 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 2.854549e-01 | 0.544 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.858054e-01 | 0.544 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 2.889215e-01 | 0.539 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 2.898799e-01 | 0.538 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 2.939910e-01 | 0.532 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.962411e-01 | 0.528 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 2.998749e-01 | 0.523 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 2.998749e-01 | 0.523 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.998749e-01 | 0.523 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 3.004567e-01 | 0.522 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 3.112414e-01 | 0.507 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.112696e-01 | 0.507 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 3.172583e-01 | 0.499 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 3.172583e-01 | 0.499 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 3.172583e-01 | 0.499 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 3.172583e-01 | 0.499 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 3.172583e-01 | 0.499 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 3.172583e-01 | 0.499 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 3.172583e-01 | 0.499 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 3.172583e-01 | 0.499 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 3.172583e-01 | 0.499 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 3.172583e-01 | 0.499 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 3.172583e-01 | 0.499 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.173147e-01 | 0.499 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 3.173147e-01 | 0.499 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.173147e-01 | 0.499 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 3.173147e-01 | 0.499 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.217317e-01 | 0.493 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 3.217317e-01 | 0.493 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.324118e-01 | 0.478 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 3.324118e-01 | 0.478 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 3.346508e-01 | 0.475 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 3.346508e-01 | 0.475 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 3.346508e-01 | 0.475 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 3.346508e-01 | 0.475 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 3.370884e-01 | 0.472 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 3.370884e-01 | 0.472 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 3.370884e-01 | 0.472 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 3.370884e-01 | 0.472 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 3.443769e-01 | 0.463 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.490724e-01 | 0.457 | 0 | 0 |
| Metabolism of ingested MeSeO2H into MeSeH | R-HSA-5263617 | 3.490724e-01 | 0.457 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 3.490724e-01 | 0.457 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.490724e-01 | 0.457 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.490724e-01 | 0.457 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 3.490724e-01 | 0.457 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 3.490724e-01 | 0.457 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.490724e-01 | 0.457 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 3.490724e-01 | 0.457 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 3.490724e-01 | 0.457 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 3.490724e-01 | 0.457 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 3.490724e-01 | 0.457 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 3.491603e-01 | 0.457 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 3.602344e-01 | 0.443 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.628783e-01 | 0.440 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 3.630379e-01 | 0.440 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 3.659396e-01 | 0.437 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 3.686183e-01 | 0.433 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 3.689024e-01 | 0.433 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 3.689024e-01 | 0.433 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 3.689024e-01 | 0.433 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 3.757182e-01 | 0.425 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.757182e-01 | 0.425 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 3.794058e-01 | 0.421 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.794058e-01 | 0.421 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.794058e-01 | 0.421 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 3.794058e-01 | 0.421 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 3.794058e-01 | 0.421 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 3.794058e-01 | 0.421 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 3.794058e-01 | 0.421 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 3.794058e-01 | 0.421 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.794058e-01 | 0.421 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 3.794058e-01 | 0.421 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 3.794058e-01 | 0.421 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.794058e-01 | 0.421 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.857698e-01 | 0.414 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 3.857698e-01 | 0.414 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 3.857698e-01 | 0.414 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 3.857698e-01 | 0.414 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.857698e-01 | 0.414 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 3.885048e-01 | 0.411 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 4.012264e-01 | 0.397 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 4.024373e-01 | 0.395 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 4.024373e-01 | 0.395 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 4.024373e-01 | 0.395 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 4.024373e-01 | 0.395 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 4.083275e-01 | 0.389 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 4.083275e-01 | 0.389 | 0 | 0 |
| RSK activation | R-HSA-444257 | 4.083275e-01 | 0.389 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 4.083275e-01 | 0.389 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 4.083275e-01 | 0.389 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 4.083275e-01 | 0.389 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 4.083275e-01 | 0.389 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 4.083275e-01 | 0.389 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 4.083275e-01 | 0.389 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 4.083275e-01 | 0.389 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 4.083275e-01 | 0.389 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 4.083275e-01 | 0.389 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 4.083275e-01 | 0.389 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 4.083275e-01 | 0.389 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 4.083275e-01 | 0.389 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 4.083275e-01 | 0.389 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 4.083275e-01 | 0.389 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 4.188868e-01 | 0.378 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 4.188868e-01 | 0.378 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 4.188868e-01 | 0.378 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 4.189482e-01 | 0.378 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 4.283154e-01 | 0.368 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 4.283154e-01 | 0.368 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.335912e-01 | 0.363 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 4.351025e-01 | 0.361 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 4.351025e-01 | 0.361 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 4.351025e-01 | 0.361 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 4.359030e-01 | 0.361 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 4.359030e-01 | 0.361 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 4.359030e-01 | 0.361 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 4.359030e-01 | 0.361 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 4.359030e-01 | 0.361 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 4.359030e-01 | 0.361 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 4.359030e-01 | 0.361 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 4.359030e-01 | 0.361 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 4.359030e-01 | 0.361 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 4.359030e-01 | 0.361 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 4.359030e-01 | 0.361 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 4.359030e-01 | 0.361 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 4.359030e-01 | 0.361 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 4.359030e-01 | 0.361 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 4.510704e-01 | 0.346 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 4.510704e-01 | 0.346 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.510704e-01 | 0.346 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 4.510704e-01 | 0.346 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 4.510704e-01 | 0.346 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.510704e-01 | 0.346 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 4.512552e-01 | 0.346 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 4.621949e-01 | 0.335 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.621949e-01 | 0.335 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 4.621949e-01 | 0.335 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 4.621949e-01 | 0.335 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.621949e-01 | 0.335 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 4.621949e-01 | 0.335 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 4.621949e-01 | 0.335 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.635014e-01 | 0.334 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 4.640690e-01 | 0.333 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 4.649621e-01 | 0.333 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 4.667785e-01 | 0.331 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 4.667785e-01 | 0.331 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 4.667785e-01 | 0.331 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 4.667785e-01 | 0.331 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 4.675482e-01 | 0.330 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 4.675482e-01 | 0.330 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 4.756265e-01 | 0.323 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 4.801693e-01 | 0.319 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 4.822162e-01 | 0.317 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 4.822162e-01 | 0.317 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 4.822162e-01 | 0.317 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 4.822162e-01 | 0.317 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 4.872629e-01 | 0.312 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 4.872629e-01 | 0.312 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 4.872629e-01 | 0.312 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 4.872629e-01 | 0.312 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 4.872629e-01 | 0.312 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 4.872629e-01 | 0.312 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 4.872629e-01 | 0.312 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 4.872629e-01 | 0.312 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.872629e-01 | 0.312 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.872629e-01 | 0.312 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 4.872629e-01 | 0.312 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 4.903264e-01 | 0.310 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 4.973748e-01 | 0.303 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 4.973748e-01 | 0.303 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.973748e-01 | 0.303 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 4.973748e-01 | 0.303 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 5.004007e-01 | 0.301 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 5.097901e-01 | 0.293 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 5.111639e-01 | 0.291 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 5.111639e-01 | 0.291 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 5.111639e-01 | 0.291 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 5.111639e-01 | 0.291 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 5.111639e-01 | 0.291 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 5.111639e-01 | 0.291 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 5.111639e-01 | 0.291 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 5.111639e-01 | 0.291 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 5.111639e-01 | 0.291 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 5.111639e-01 | 0.291 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 5.111639e-01 | 0.291 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 5.122466e-01 | 0.291 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 5.122466e-01 | 0.291 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.122466e-01 | 0.291 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 5.227815e-01 | 0.282 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 5.268256e-01 | 0.278 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 5.272962e-01 | 0.278 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 5.300826e-01 | 0.276 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 5.339522e-01 | 0.272 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 5.339522e-01 | 0.272 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 5.339522e-01 | 0.272 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 5.339522e-01 | 0.272 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 5.339522e-01 | 0.272 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 5.339522e-01 | 0.272 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 5.339522e-01 | 0.272 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 5.339522e-01 | 0.272 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 5.339522e-01 | 0.272 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 5.339522e-01 | 0.272 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 5.339522e-01 | 0.272 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 5.339522e-01 | 0.272 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.339522e-01 | 0.272 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 5.342044e-01 | 0.272 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 5.414475e-01 | 0.266 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 5.454710e-01 | 0.263 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 5.469750e-01 | 0.262 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.493809e-01 | 0.260 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.493809e-01 | 0.260 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 5.495119e-01 | 0.260 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 5.530227e-01 | 0.257 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 5.530227e-01 | 0.257 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 5.550858e-01 | 0.256 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 5.550858e-01 | 0.256 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 5.550858e-01 | 0.256 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.556794e-01 | 0.255 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 5.556794e-01 | 0.255 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 5.556794e-01 | 0.255 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.556794e-01 | 0.255 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.556794e-01 | 0.255 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.556794e-01 | 0.255 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.556794e-01 | 0.255 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 5.556794e-01 | 0.255 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 5.565770e-01 | 0.254 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 5.687602e-01 | 0.245 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 5.763949e-01 | 0.239 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 5.763949e-01 | 0.239 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 5.763949e-01 | 0.239 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 5.763949e-01 | 0.239 | 0 | 0 |
| Formation of the active cofactor, UDP-glucuronate | R-HSA-173599 | 5.763949e-01 | 0.239 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 5.763949e-01 | 0.239 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 5.763949e-01 | 0.239 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 5.763949e-01 | 0.239 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 5.763949e-01 | 0.239 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 5.775267e-01 | 0.238 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 5.775267e-01 | 0.238 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 5.821280e-01 | 0.235 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 5.821280e-01 | 0.235 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 5.821280e-01 | 0.235 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 5.951879e-01 | 0.225 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 5.951879e-01 | 0.225 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 5.957239e-01 | 0.225 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 5.961459e-01 | 0.225 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 5.993279e-01 | 0.222 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 5.993279e-01 | 0.222 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 6.064498e-01 | 0.217 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 6.079397e-01 | 0.216 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 6.079397e-01 | 0.216 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 6.145781e-01 | 0.211 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 6.149771e-01 | 0.211 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 6.149771e-01 | 0.211 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 6.149771e-01 | 0.211 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 6.149771e-01 | 0.211 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 6.149771e-01 | 0.211 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 6.149771e-01 | 0.211 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 6.149771e-01 | 0.211 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.149771e-01 | 0.211 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 6.149771e-01 | 0.211 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 6.196626e-01 | 0.208 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 6.203836e-01 | 0.207 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 6.295632e-01 | 0.201 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 6.295632e-01 | 0.201 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 6.325207e-01 | 0.199 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 6.329313e-01 | 0.199 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 6.329313e-01 | 0.199 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 6.329313e-01 | 0.199 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 6.329313e-01 | 0.199 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 6.329313e-01 | 0.199 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 6.364075e-01 | 0.196 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.392843e-01 | 0.194 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.443524e-01 | 0.191 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 6.443524e-01 | 0.191 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 6.488251e-01 | 0.188 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 6.500493e-01 | 0.187 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.500493e-01 | 0.187 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.500493e-01 | 0.187 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 6.500493e-01 | 0.187 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 6.500493e-01 | 0.187 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 6.558809e-01 | 0.183 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 6.558809e-01 | 0.183 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 6.558809e-01 | 0.183 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 6.581850e-01 | 0.182 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 6.636357e-01 | 0.178 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 6.636357e-01 | 0.178 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 6.638060e-01 | 0.178 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.663700e-01 | 0.176 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 6.663700e-01 | 0.176 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 6.663700e-01 | 0.176 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 6.663700e-01 | 0.176 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 6.663700e-01 | 0.176 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 6.663700e-01 | 0.176 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.663700e-01 | 0.176 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 6.673637e-01 | 0.176 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.673637e-01 | 0.176 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.763612e-01 | 0.170 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 6.780389e-01 | 0.169 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 6.780389e-01 | 0.169 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 6.780389e-01 | 0.169 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 6.780389e-01 | 0.169 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 6.809563e-01 | 0.167 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 6.819305e-01 | 0.166 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 6.819305e-01 | 0.166 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.819305e-01 | 0.166 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.819305e-01 | 0.166 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 6.819305e-01 | 0.166 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 6.819305e-01 | 0.166 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 6.819305e-01 | 0.166 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 6.819305e-01 | 0.166 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 6.886746e-01 | 0.162 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 6.886746e-01 | 0.162 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 6.894258e-01 | 0.162 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 6.967661e-01 | 0.157 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.967661e-01 | 0.157 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.967661e-01 | 0.157 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 6.967661e-01 | 0.157 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.967661e-01 | 0.157 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 6.967661e-01 | 0.157 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 6.967661e-01 | 0.157 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 6.990195e-01 | 0.156 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 7.022695e-01 | 0.153 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 7.090778e-01 | 0.149 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 7.109107e-01 | 0.148 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 7.109107e-01 | 0.148 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 7.109107e-01 | 0.148 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 7.109107e-01 | 0.148 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.109107e-01 | 0.148 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 7.109107e-01 | 0.148 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 7.163399e-01 | 0.145 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 7.188535e-01 | 0.143 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 7.233494e-01 | 0.141 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 7.243962e-01 | 0.140 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.243962e-01 | 0.140 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.372535e-01 | 0.132 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 7.372535e-01 | 0.132 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.372535e-01 | 0.132 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.372535e-01 | 0.132 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.372535e-01 | 0.132 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 7.372535e-01 | 0.132 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.372535e-01 | 0.132 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 7.375754e-01 | 0.132 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 7.465311e-01 | 0.127 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.478695e-01 | 0.126 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 7.495117e-01 | 0.125 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 7.495117e-01 | 0.125 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 7.495117e-01 | 0.125 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 7.495117e-01 | 0.125 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 7.611988e-01 | 0.119 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 7.611988e-01 | 0.119 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 7.611988e-01 | 0.119 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 7.611988e-01 | 0.119 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 7.611988e-01 | 0.119 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 7.611988e-01 | 0.119 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 7.611988e-01 | 0.119 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.636568e-01 | 0.117 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.723412e-01 | 0.112 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.723412e-01 | 0.112 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 7.723412e-01 | 0.112 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.723412e-01 | 0.112 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.723412e-01 | 0.112 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 7.723412e-01 | 0.112 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 7.771910e-01 | 0.109 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 7.775520e-01 | 0.109 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 7.829644e-01 | 0.106 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 7.829644e-01 | 0.106 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 7.829644e-01 | 0.106 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.829644e-01 | 0.106 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.829644e-01 | 0.106 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 7.864397e-01 | 0.104 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 7.874587e-01 | 0.104 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 7.930924e-01 | 0.101 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 7.930924e-01 | 0.101 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.930924e-01 | 0.101 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.964050e-01 | 0.099 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.027485e-01 | 0.095 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.027485e-01 | 0.095 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.027485e-01 | 0.095 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 8.087865e-01 | 0.092 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 8.087865e-01 | 0.092 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 8.091245e-01 | 0.092 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 8.091245e-01 | 0.092 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 8.119544e-01 | 0.090 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 8.133955e-01 | 0.090 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 8.207313e-01 | 0.086 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.207313e-01 | 0.086 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.207313e-01 | 0.086 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 8.207313e-01 | 0.086 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.207313e-01 | 0.086 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 8.207313e-01 | 0.086 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 8.224537e-01 | 0.085 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 8.252626e-01 | 0.083 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.288000e-01 | 0.082 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.288000e-01 | 0.082 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.290990e-01 | 0.081 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 8.292495e-01 | 0.081 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 8.306873e-01 | 0.081 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 8.370766e-01 | 0.077 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 8.370766e-01 | 0.077 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 8.446822e-01 | 0.073 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 8.446822e-01 | 0.073 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.446822e-01 | 0.073 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 8.446822e-01 | 0.073 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 8.466299e-01 | 0.072 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.474232e-01 | 0.072 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.519333e-01 | 0.070 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.519333e-01 | 0.070 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 8.519333e-01 | 0.070 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.588463e-01 | 0.066 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.643081e-01 | 0.063 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.654369e-01 | 0.063 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.654369e-01 | 0.063 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.654369e-01 | 0.063 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 8.654369e-01 | 0.063 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.717201e-01 | 0.060 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 8.726277e-01 | 0.059 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 8.773147e-01 | 0.057 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 8.777104e-01 | 0.057 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 8.777104e-01 | 0.057 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 8.777104e-01 | 0.057 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 8.783448e-01 | 0.056 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.834213e-01 | 0.054 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 8.834213e-01 | 0.054 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 8.845881e-01 | 0.053 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.845881e-01 | 0.053 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.888658e-01 | 0.051 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 8.904370e-01 | 0.050 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.940563e-01 | 0.049 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.940563e-01 | 0.049 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 8.990047e-01 | 0.046 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 8.990047e-01 | 0.046 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.995306e-01 | 0.046 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.037223e-01 | 0.044 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.037223e-01 | 0.044 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.059115e-01 | 0.043 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.075535e-01 | 0.042 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.082198e-01 | 0.042 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.082198e-01 | 0.042 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.150112e-01 | 0.039 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.165951e-01 | 0.038 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.165951e-01 | 0.038 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.165951e-01 | 0.038 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.196843e-01 | 0.036 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.242069e-01 | 0.034 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.242069e-01 | 0.034 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 9.242069e-01 | 0.034 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 9.242069e-01 | 0.034 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.244750e-01 | 0.034 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.277486e-01 | 0.033 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.277486e-01 | 0.033 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.311250e-01 | 0.031 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.311250e-01 | 0.031 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.311250e-01 | 0.031 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.347910e-01 | 0.029 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.374123e-01 | 0.028 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.451652e-01 | 0.024 | 0 | 0 |
| Glucuronidation | R-HSA-156588 | 9.483193e-01 | 0.023 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.507354e-01 | 0.022 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.552345e-01 | 0.020 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.573277e-01 | 0.019 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.593231e-01 | 0.018 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.593231e-01 | 0.018 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.630388e-01 | 0.016 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.661629e-01 | 0.015 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.664154e-01 | 0.015 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.679864e-01 | 0.014 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.679864e-01 | 0.014 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.711117e-01 | 0.013 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.722725e-01 | 0.012 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.722725e-01 | 0.012 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.722725e-01 | 0.012 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.759853e-01 | 0.011 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.759853e-01 | 0.011 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.771091e-01 | 0.010 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.771091e-01 | 0.010 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.792016e-01 | 0.009 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.836346e-01 | 0.007 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.837587e-01 | 0.007 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.844008e-01 | 0.007 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.844008e-01 | 0.007 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.850464e-01 | 0.007 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.851270e-01 | 0.007 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.858275e-01 | 0.006 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.862345e-01 | 0.006 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.871237e-01 | 0.006 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.876753e-01 | 0.005 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.877268e-01 | 0.005 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.885363e-01 | 0.005 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.893719e-01 | 0.005 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.919977e-01 | 0.003 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.940250e-01 | 0.003 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.942656e-01 | 0.002 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.947523e-01 | 0.002 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.947938e-01 | 0.002 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.948266e-01 | 0.002 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.961219e-01 | 0.002 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.969491e-01 | 0.001 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.970932e-01 | 0.001 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.971555e-01 | 0.001 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.972296e-01 | 0.001 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.974356e-01 | 0.001 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.980316e-01 | 0.001 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.985629e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.991676e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.991757e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.995549e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.995727e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.995758e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.996823e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.997250e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.997338e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.998601e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999208e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999413e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999471e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999885e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999899e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999937e-01 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.999978e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |